Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
NM_000546.6(TP53):c.1177G>T (p.Asp393Tyr)	TP53	D234Y, D261Y, D393Y, D354Y	Hereditary cancer-predisposing syndrome	VCV001741120	17	7572932	17	7669614	1741120	1808497	rs1192921623	NC_000017.11:7669613:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jul 12, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.1164A>T (p.Glu388Asp)	TP53	E229D, E256D, E349D, E388D	Hereditary cancer-predisposing syndrome	VCV001737684	17	7572945	17	7669627	1737684	1787548	rs2072832085	NC_000017.11:7669626:T:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Aug 6, 2021	criteria provided, single submitter							
NM_000546.6(TP53):c.1163A>C (p.Glu388Ala)	TP53	E256A, E349A, E388A, E229A	Li-Fraumeni syndrome	VCV000141425	17	7572946	17	7669628	141425	151139	rs587781736	NC_000017.11:7669627:T:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 10, 2022	reviewed by expert panel							
NM_000546.6(TP53):c.1162G>C (p.Glu388Gln)	TP53	E229Q, E349Q, E388Q, E256Q	Hereditary cancer-predisposing syndrome	VCV001737291	17	7572947	17	7669629	1737291	1790490	rs2150988225	NC_000017.11:7669628:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jul 11, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.1159A>C (p.Thr387Pro)	TP53	T255P, T387P, T228P, T348P	Hereditary cancer-predisposing syndrome	VCV002585882	17	7572950	17	7669632	2585882	2753442	rs2150988269	NC_000017.11:7669631:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Aug 23, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.1155C>A (p.Phe385Leu)	TP53	F346L, F226L, F253L, F385L	Hereditary cancer-predisposing syndrome	VCV001735082	17	7572954	17	7669636	1735082	1793421	rs2150988307	NC_000017.11:7669635:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Dec 10, 2021	criteria provided, single submitter							
NM_000546.6(TP53):c.1153T>C (p.Phe385Leu)	TP53	F385L, F253L, F346L, F226L	Hereditary cancer-predisposing syndrome	VCV000485029	17	7572956	17	7669638	485029	479204	rs1555524094	NC_000017.11:7669637:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 7, 2021	criteria provided, single submitter							
NM_000546.6(TP53):c.1151T>C (p.Met384Thr)	TP53	M252T, M345T, M384T, M225T	Li-Fraumeni syndrome	VCV000406575	17	7572958	17	7669640	406575	402994	rs1060501196	NC_000017.11:7669639:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.1150A>G (p.Met384Val)	TP53	M252V, M345V, M384V, M225V	Li-Fraumeni syndrome	VCV000182939	17	7572959	17	7669641	182939	180986	rs730882009	NC_000017.11:7669640:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.1136G>A (p.Arg379His)	TP53	R247H, R340H, R379H, R220H	Li-Fraumeni syndrome	VCV000246221	17	7572973	17	7669655	246221	245067	rs863224682	NC_000017.11:7669654:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.1136G>T (p.Arg379Leu)	TP53	R247L, R340L, R379L, R220L	Li-Fraumeni syndrome	VCV000216463	17	7572973	17	7669655	216463	213384	rs863224682	NC_000017.11:7669654:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.1135C>A (p.Arg379Ser)	TP53	R247S, R340S, R379S, R220S	Li-Fraumeni syndrome	VCV000186762	17	7572974	17	7669656	186762	185334	rs749061599	NC_000017.11:7669655:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.1132T>A (p.Ser378Thr)	TP53	S219T, S378T, S246T, S339T	Hereditary cancer-predisposing syndrome	VCV003972449	17	7572977	17	7669659	3972449	4089461		NC_000017.11:7669658:A:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Apr 21, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.1123C>A (p.Gln375Lys)	TP53	Q216K, Q375K, Q336K, Q243K	Hereditary cancer-predisposing syndrome	VCV001798385	17	7572986	17	7669668	1798385	1856525	rs1555524156	NC_000017.11:7669667:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 7, 2021	criteria provided, single submitter							
NM_000546.6(TP53):c.1121G>T (p.Gly374Val)	TP53	G242V, G215V, G335V, G374V	Hereditary cancer-predisposing syndrome	VCV001797938	17	7572988	17	7669670	1797938	1853557	rs2543452309	NC_000017.11:7669669:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Aug 7, 2020	criteria provided, single submitter							
NM_000546.6(TP53):c.1120G>C (p.Gly374Arg)	TP53	G242R, G335R, G374R, G215R	Li-Fraumeni syndrome	VCV000230269	17	7572989	17	7669671	230269	236436	rs587781858	NC_000017.11:7669670:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1096T>G (p.Ser366Ala)	TP53	S234A, S327A, S366A, S207A	Li-Fraumeni syndrome	VCV000135360	17	7573931	17	7670613	135360	139099	rs17881470	NC_000017.11:7670612:A:C	single nucleotide variant	missense variant|3 prime UTR variant	Benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1093C>T (p.His365Tyr)	TP53	H233Y, H326Y, H365Y, H206Y	Li-Fraumeni syndrome	VCV000080708	17	7573934	17	7670616	80708	91599	rs267605075	NC_000017.11:7670615:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1079G>C (p.Gly360Ala)	TP53	G228A, G321A, G360A, G201A	Li-Fraumeni syndrome	VCV000142003	17	7573948	17	7670630	142003	151717	rs35993958	NC_000017.11:7670629:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1067G>A (p.Gly356Glu)	TP53	G317E, G197E, G356E, G224E	Hereditary cancer-predisposing syndrome	VCV003460336	17	7573960	17	7670642	3460336	3611147		NC_000017.11:7670641:C:T	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Nov 18, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.1066G>C (p.Gly356Arg)	TP53	G224R, G317R, G356R, G197R	Li-Fraumeni syndrome	VCV000234059	17	7573961	17	7670643	234059	236443	rs766786605	NC_000017.11:7670642:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Sep 6, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1063G>A (p.Ala355Thr)	TP53	A316T, A355T, A196T, A223T	Hereditary cancer-predisposing syndrome	VCV001781085	17	7573964	17	7670646	1781085	1839353	rs1157427821	NC_000017.11:7670645:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Jan 5, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.1061A>C (p.Gln354Pro)	TP53	Q222P, Q354P, Q195P, Q315P	Hereditary cancer-predisposing syndrome	VCV003328171	17	7573966	17	7670648	3328171	3486884		NC_000017.11:7670647:T:G	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Likely benign	May 8, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.1061A>T (p.Gln354Leu)	TP53	Q195L, Q222L, Q315L, Q354L	Hereditary cancer-predisposing syndrome	VCV003232047	17	7573966	17	7670648	3232047	3385587	rs752142489	NC_000017.11:7670647:T:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Dec 29, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.1060C>A (p.Gln354Lys)	TP53	Q222K, Q315K, Q354K, Q195K	Li-Fraumeni syndrome	VCV000231485	17	7573967	17	7670649	231485	236444	rs755394212	NC_000017.11:7670648:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Benign	Sep 6, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1049T>G (p.Leu350Arg)	TP53	L350R, L191R, L218R, L311R	Hereditary cancer-predisposing syndrome	VCV004189250	17	7573978	17	7670660	4189250	4304820		NC_000017.11:7670659:A:C	single nucleotide variant	3 prime UTR variant|non-coding transcript variant|missense variant	Likely benign	Aug 18, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.1046A>G (p.Glu349Gly)	TP53	E190G, E217G, E310G, E349G	Hereditary cancer-predisposing syndrome	VCV001775423	17	7573981	17	7670663	1775423	1830620	rs2543472094	NC_000017.11:7670662:T:C	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Dec 21, 2020	criteria provided, single submitter							
NM_000546.6(TP53):c.1040C>G (p.Ala347Gly)	TP53	A188G, A215G, A308G, A347G	Hereditary breast ovarian cancer syndrome	VCV002683739	17	7573987	17	7670669	2683739	2844772	rs397516434	NC_000017.11:7670668:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Nov 14, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.1040C>A (p.Ala347Asp)	TP53	A215D, A308D, A347D, A188D	Li-Fraumeni syndrome	VCV000043587	17	7573987	17	7670669	43587	52756	rs397516434	NC_000017.11:7670668:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1031T>C (p.Leu344Pro)	TP53	L344P, L212P, L305P, L185P	Li-Fraumeni syndrome	VCV000012375	17	7573996	17	7670678	12375	27414	rs121912662	NC_000017.11:7670677:A:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1029G>T (p.Glu343Asp)	TP53	E343D, E184D, E304D, E211D	Hereditary cancer-predisposing syndrome	VCV003460327	17	7573998	17	7670680	3460327	3611138		NC_000017.11:7670679:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Benign	Oct 24, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.1024_1025delinsTT (p.Arg342Leu)	TP53	R303L, R183L, R210L, R342L	Hereditary cancer-predisposing syndrome	VCV000822031	17	7574002 - 7574003	17	7670684 - 7670685	822031	814450	rs1597349305	NC_000017.11:7670683:CG:AA	Indel	missense variant|3 prime UTR variant	Benign	Jun 11, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.1025G>A (p.Arg342Gln)	TP53	R210Q, R303Q, R342Q, R183Q	Li-Fraumeni syndrome	VCV000233136	17	7574002	17	7670684	233136	236445	rs375338359	NC_000017.11:7670683:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Sep 6, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1025G>C (p.Arg342Pro)	TP53	R210P, R303P, R342P, R183P	Li-Fraumeni syndrome|Diffuse glioma, H3 G34 mutant	VCV000215996	17	7574002	17	7670684	215996	213385	rs375338359	NC_000017.11:7670683:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic	Sep 6, 2024	reviewed by expert panel	Tier I - Strong	Aug 5, 2024	criteria provided, single submitter				
NM_000546.6(TP53):c.1023C>G (p.Phe341Leu)	TP53	F209L, F302L, F182L, F341L	Hereditary cancer-predisposing syndrome	VCV002585878	17	7574004	17	7670686	2585878	2753438	rs864622369	NC_000017.11:7670685:G:C	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Jun 26, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.1021_1022delinsAG (p.Phe341Ser)	TP53	F209S, F182S, F302S, F341S	Hereditary cancer-predisposing syndrome	VCV002450748	17	7574005 - 7574006	17	7670687 - 7670688	2450748	2423234	rs2543473385	NC_000017.11:7670686:AA:CT	Indel	missense variant|3 prime UTR variant|non-coding transcript variant	Likely pathogenic	Dec 29, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.1020G>C (p.Met340Ile)	TP53	M181I, M208I, M301I, M340I	not specified	VCV003256325	17	7574007	17	7670689	3256325	3415087		NC_000017.11:7670688:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Mar 4, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.1020G>T (p.Met340Ile)	TP53	M301I, M208I, M340I, M181I	Hereditary cancer-predisposing syndrome	VCV001759327	17	7574007	17	7670689	1759327	1816234	rs1463722976	NC_000017.11:7670688:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Oct 30, 2020	criteria provided, single submitter							
NM_000546.6(TP53):c.1015G>C (p.Glu339Gln)	TP53	E207Q, E300Q, E339Q, E180Q	Li-Fraumeni syndrome	VCV000141893	17	7574012	17	7670694	141893	151607	rs17882252	NC_000017.11:7670693:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Sep 6, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.1010G>C (p.Arg337Pro)	TP53	R205P, R298P, R337P, R178P	Li-Fraumeni syndrome	VCV000177879	17	7574017	17	7670699	177879	176640	rs121912664	NC_000017.11:7670698:C:G	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	May 7, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.1010G>T (p.Arg337Leu)	TP53	R205L, R298L, R337L, R178L	Li-Fraumeni syndrome|Rhabdomyosarcoma	VCV000142828	17	7574017	17	7670699	142828	152542	rs121912664	NC_000017.11:7670698:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	May 7, 2025	reviewed by expert panel	Tier I - Strong	Mar 22, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.1010G>A (p.Arg337His)	TP53	R337H, R205H, R298H, R178H	Carcinoma of pancreas|Nasopharyngeal carcinoma|Adrenocortical carcinoma, hereditary|Bone marrow failure syndrome 5|Hepatocellular carcinoma|Bone osteosarcoma|Familial cancer of breast|Basal cell carcinoma, susceptibility to, 7|Li-Fraumeni syndrome 1|Colorectal cancer|Choroid plexus papilloma|Glioma susceptibility 1|Hereditary cancer-predisposing syndrome|not provided|Breast neoplasm|Hereditary breast ovarian cancer syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Neuroblastoma	VCV000012379	17	7574017	17	7670699	12379	27418	rs121912664	NC_000017.11:7670698:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic/Likely pathogenic/Pathogenic, low penetrance	Aug 12, 2025	criteria provided, multiple submitters, no conflicts	Tier II - Potential	Jul 12, 2024	criteria provided, single submitter				
NM_000546.6(TP53):c.1009C>A (p.Arg337Ser)	TP53	R178S, R205S, R298S, R337S	Li-Fraumeni syndrome	VCV001019612	17	7574018	17	7670700	1019612	1013144	rs587782529	NC_000017.11:7670699:G:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	May 7, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.1009C>G (p.Arg337Gly)	TP53	R205G, R298G, R337G, R178G	Li-Fraumeni syndrome	VCV000237938	17	7574018	17	7670700	237938	242977	rs587782529	NC_000017.11:7670699:G:C	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	May 7, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.1009C>T (p.Arg337Cys)	TP53	R205C, R298C, R337C, R178C	Li-Fraumeni syndrome|Neoplasm	VCV000142536	17	7574018	17	7670700	142536	152250	rs587782529	NC_000017.11:7670699:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Pathogenic	May 7, 2025	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.1006G>C (p.Glu336Gln)	TP53	E204Q, E297Q, E177Q, E336Q	Hereditary cancer-predisposing syndrome	VCV002450754	17	7574021	17	7670703	2450754	2423240	rs2150995270	NC_000017.11:7670702:C:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Feb 3, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.1004G>T (p.Arg335Leu)	TP53	R203L, R296L, R335L, R176L	Hereditary cancer-predisposing syndrome	VCV003328160	17	7574023	17	7670705	3328160	3486873		NC_000017.11:7670704:C:A	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Jun 18, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.1003C>T (p.Arg335Cys)	TP53	R203C, R296C, R335C, R176C	Li-Fraumeni syndrome	VCV000141159	17	7574024	17	7670706	141159	150873	rs375444154	NC_000017.11:7670705:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Feb 6, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.1000G>T (p.Gly334Trp)	TP53	G202W, G295W, G334W, G175W	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000428876	17	7574027	17	7670709	428876	420637	rs730882028	NC_000017.11:7670708:C:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Jun 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.998G>A (p.Arg333His)	TP53	R201H, R294H, R333H, R174H	Li-Fraumeni syndrome	VCV000142273	17	7574029	17	7670711	142273	151987	rs573154688	NC_000017.11:7670710:C:T	single nucleotide variant	missense variant|3 prime UTR variant	Benign	Mar 4, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.997C>T (p.Arg333Cys)	TP53	R201C, R294C, R333C, R174C	Li-Fraumeni syndrome	VCV000184745	17	7574030	17	7670712	184745	185338	rs769934890	NC_000017.11:7670711:G:A	single nucleotide variant	missense variant|3 prime UTR variant	Likely benign	Feb 6, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.995T>A (p.Ile332Asn)	TP53	I173N, I200N, I293N, I332N	Hereditary cancer-predisposing syndrome	VCV001768732	17	7574032	17	7670714	1768732	1825732	rs2150995433	NC_000017.11:7670713:A:T	single nucleotide variant	missense variant|3 prime UTR variant	Likely pathogenic	Feb 4, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.994A>C (p.Ile332Leu)	TP53	I200L, I293L, I173L, I332L	Hereditary cancer-predisposing syndrome	VCV004189263	17	7574033	17	7670715	4189263	4304833		NC_000017.11:7670714:T:G	single nucleotide variant	missense variant|3 prime UTR variant|non-coding transcript variant	Likely benign	Jul 16, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.993+312C>T	TP53	S214L, S346L, S187L, S307L	not specified|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000492650	17	7576541	17	7673223	492650	485325	rs756952434	NC_000017.11:7673222:G:A	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Likely benign	Jun 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.993+307C>G	TP53	N212K, N344K, N305K, N185K	Hereditary cancer-predisposing syndrome	VCV000492647	17	7576546	17	7673228	492647	485506	rs200274944	NC_000017.11:7673227:G:C	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Likely benign	Apr 8, 2015	criteria provided, single submitter							
NM_000546.6(TP53):c.993+290T>C	TP53	C207R, C339R, C180R, C300R	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000492646	17	7576563	17	7673245	492646	485507	rs1642789	NC_000017.11:7673244:A:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Likely benign	Jun 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.993+287T>C	TP53	W206R, W338R, W179R, W299R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000492645	17	7576566	17	7673248	492645	485095	rs749361930	NC_000017.11:7673247:A:G	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Likely benign	Jul 7, 2023	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.993+285G>A	TP53	R205Q, R337Q, R178Q, R298Q	Hereditary cancer-predisposing syndrome	VCV000492644	17	7576568	17	7673250	492644	485097	rs771319678	NC_000017.11:7673249:C:T	single nucleotide variant	missense variant|3 prime UTR variant|intron variant	Likely benign	Sep 24, 2017	criteria provided, single submitter							
NM_000546.6(TP53):c.993+223T>C	TP53	C209R, C341R, C302R, C182R	Hereditary cancer-predisposing syndrome	VCV000492638	17	7576630	17	7673312	492638	485310	rs3021068	NC_000017.11:7673311:A:G	single nucleotide variant	missense variant|intron variant	Likely benign	Aug 17, 2017	criteria provided, single submitter							
NM_000546.6(TP53):c.993+223T>G	TP53	C209G, C341G, C182G, C302G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Hereditary breast ovarian cancer syndrome	VCV000135361	17	7576630	17	7673312	135361	139100	rs3021068	NC_000017.11:7673311:A:C	single nucleotide variant	missense variant|intron variant	Benign/Likely benign	Feb 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.993+216A>C	TP53	K206N, K338N, K179N, K299N	Hereditary cancer-predisposing syndrome	VCV000492637	17	7576637	17	7673319	492637	485100	rs761303879	NC_000017.11:7673318:T:G	single nucleotide variant	missense variant|intron variant	Likely benign	Oct 2, 2017	criteria provided, single submitter							
NM_000546.6(TP53):c.993+203C>T	TP53	T175I, T295I, T334I, T202I	Hereditary cancer-predisposing syndrome	VCV000924895	17	7576650	17	7673332	924895	916570	rs2073127723	NC_000017.11:7673331:G:A	single nucleotide variant	missense variant|intron variant	Likely benign	Dec 3, 2018	criteria provided, single submitter							
NM_000546.6(TP53):c.993+199C>G	TP53	Q201E, Q333E, Q174E, Q294E	Hereditary cancer-predisposing syndrome	VCV000492635	17	7576654	17	7673336	492635	485105	rs764851816	NC_000017.11:7673335:G:C	single nucleotide variant	missense variant|intron variant	Likely benign	Feb 13, 2017	criteria provided, single submitter							
NM_000546.6(TP53):c.978A>C (p.Glu326Asp)	TP53	E194D, E167D, E287D, E326D	Hereditary cancer-predisposing syndrome	VCV003972458	17	7576868	17	7673550	3972458	4089470		NC_000017.11:7673549:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 23, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.977A>T (p.Glu326Val)	TP53	E167V, E194V, E287V, E326V	Acute myeloid leukemia	VCV002578514	17	7576869	17	7673551	2578514	2743448	rs2151011218	NC_000017.11:7673550:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic		no assertion criteria provided							
NM_000546.6(TP53):c.972T>A (p.Asp324Glu)	TP53	D165E, D192E, D285E, D324E	Hereditary cancer-predisposing syndrome	VCV002450758	17	7576874	17	7673556	2450758	2423244	rs2151011317	NC_000017.11:7673555:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 7, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.970G>A (p.Asp324Asn)	TP53	D165N, D192N, D285N, D324N	Acute myeloid leukemia	VCV002578516	17	7576876	17	7673558	2578516	2743450	rs1064794810	NC_000017.11:7673557:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign		no assertion criteria provided							
NM_000546.6(TP53):c.956A>C (p.Lys319Thr)	TP53	K187T, K160T, K280T, K319T	Hereditary cancer-predisposing syndrome	VCV003328169	17	7576890	17	7673572	3328169	3486882		NC_000017.11:7673571:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 1, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.952C>T (p.Pro318Ser)	TP53	P159S, P186S, P279S, P318S	Acute myeloid leukemia	VCV002575170	17	7576894	17	7673576	2575170	2740100	rs2151011743	NC_000017.11:7673575:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign		no assertion criteria provided							
NM_000546.6(TP53):c.949C>A (p.Gln317Lys)	TP53	Q185K, Q278K, Q317K, Q158K	Li-Fraumeni syndrome	VCV000231008	17	7576897	17	7673579	231008	236450	rs764735889	NC_000017.11:7673578:G:T	single nucleotide variant	missense variant	Benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.946C>A (p.Pro316Thr)	TP53	P184T, P277T, P316T, P157T	Li-Fraumeni syndrome	VCV000230382	17	7576900	17	7673582	230382	236451	rs772773208	NC_000017.11:7673581:G:T	single nucleotide variant	missense variant	Likely benign	Mar 4, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.943T>A (p.Ser315Thr)	TP53	S183T, S276T, S315T, S156T	Li-Fraumeni syndrome	VCV000185212	17	7576903	17	7673585	185212	185339	rs762620193	NC_000017.11:7673584:A:T	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.938G>A (p.Ser313Asn)	TP53	S154N, S181N, S313N, S274N	Hereditary cancer-predisposing syndrome	VCV002450750	17	7576908	17	7673590	2450750	2423236	rs2151012123	NC_000017.11:7673589:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jan 17, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.935C>A (p.Thr312Asn)	TP53	T180N, T312N, T153N, T273N	Hereditary cancer-predisposing syndrome	VCV001766672	17	7576911	17	7673593	1766672	1824915	rs145151284	NC_000017.11:7673592:G:T	single nucleotide variant	missense variant	Likely benign	Jun 7, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.935C>G (p.Thr312Ser)	TP53	T180S, T273S, T312S, T153S	Li-Fraumeni syndrome	VCV000141102	17	7576911	17	7673593	141102	150816	rs145151284	NC_000017.11:7673592:G:C	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.930C>G (p.Asn310Lys)	TP53	N178K, N271K, N310K, N151K	Hereditary cancer-predisposing syndrome	VCV000428879	17	7576916	17	7673598	428879	420640	rs876660829	NC_000017.11:7673597:G:C	single nucleotide variant	missense variant	Likely benign	Oct 30, 2020	criteria provided, single submitter							
NM_000546.6(TP53):c.929A>G (p.Asn310Ser)	TP53	N178S, N271S, N310S, N151S	Hereditary cancer-predisposing syndrome	VCV001766454	17	7576917	17	7673599	1766454	1815032	rs2151012288	NC_000017.11:7673598:T:C	single nucleotide variant	missense variant	Likely benign	Oct 28, 2020	criteria provided, single submitter							
NM_000546.6(TP53):c.920C>G (p.Ala307Gly)	TP53	A175G, A268G, A307G, A148G	Hereditary cancer-predisposing syndrome	VCV000485027	17	7576926	17	7673608	485027	479225	rs1457582183	NC_000017.11:7673607:G:C	single nucleotide variant	missense variant	Likely benign	May 27, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.907A>G (p.Ser303Gly)	TP53	S171G, S264G, S303G, S144G	Li-Fraumeni syndrome	VCV000142332	17	7577031	17	7673713	142332	152046	rs587782391	NC_000017.11:7673712:T:C	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.905G>C (p.Gly302Ala)	TP53	G170A, G263A, G143A, G302A	Hereditary cancer-predisposing syndrome	VCV003328162	17	7577033	17	7673715	3328162	3486875		NC_000017.11:7673714:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 18, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.899C>T (p.Pro300Leu)	TP53	P141L, P168L, P261L, P300L	Hereditary cancer-predisposing syndrome	VCV001765377	17	7577039	17	7673721	1765377	1821018	rs909643864	NC_000017.11:7673720:G:A	single nucleotide variant	missense variant	Likely benign	Dec 5, 2014	criteria provided, single submitter							
NM_000546.6(TP53):c.892G>A (p.Glu298Lys)	TP53	E166K, E259K, E298K, E139K	Li-Fraumeni syndrome	VCV000141483	17	7577046	17	7673728	141483	151197	rs201744589	NC_000017.11:7673727:C:T	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.887A>G (p.His296Arg)	TP53	H164R, H257R, H296R, H137R	not provided	VCV000100816	17	7577051	17	7673733	100816	106676	rs483352696	NC_000017.11:7673732:T:C	single nucleotide variant	missense variant	Likely pathogenic		no assertion criteria provided							
NM_000546.6(TP53):c.886C>T (p.His296Tyr)	TP53	H164Y, H257Y, H296Y, H137Y	Li-Fraumeni syndrome	VCV000132973	17	7577052	17	7673734	132973	136722	rs672601296	NC_000017.11:7673733:G:A	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.883C>T (p.Pro295Ser)	TP53	P163S, P256S, P295S, P136S	Li-Fraumeni syndrome	VCV000428862	17	7577055	17	7673737	428862	420643	rs1131691006	NC_000017.11:7673736:G:A	single nucleotide variant	missense variant	Likely benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.877G>T (p.Gly293Trp)	TP53	G161W, G254W, G293W, G134W	Li-Fraumeni syndrome	VCV000127826	17	7577061	17	7673743	127826	133283	rs587780076	NC_000017.11:7673742:C:A	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.875A>G (p.Lys292Arg)	TP53	K160R, K253R, K292R, K133R	Li-Fraumeni syndrome	VCV000406577	17	7577063	17	7673745	406577	403145	rs121912663	NC_000017.11:7673744:T:C	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.869G>A (p.Arg290His)	TP53	R158H, R251H, R290H, R131H	Li-Fraumeni syndrome	VCV000127825	17	7577069	17	7673751	127825	133282	rs55819519	NC_000017.11:7673750:C:T	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.868C>T (p.Arg290Cys)	TP53	R158C, R251C, R290C, R131C	Li-Fraumeni syndrome 1	VCV000216472	17	7577070	17	7673752	216472	213390	rs770374782	NC_000017.11:7673751:G:A	single nucleotide variant	missense variant	Likely benign	May 13, 2021	reviewed by expert panel							
NM_000546.6(TP53):c.866T>C (p.Leu289Pro)	TP53	L130P, L157P, L250P, L289P	Li-Fraumeni syndrome 1	VCV001172923	17	7577072	17	7673754	1172923	1162106	rs2151014987	NC_000017.11:7673753:A:G	single nucleotide variant	missense variant	Likely benign	Jun 16, 2021	reviewed by expert panel							
NM_000546.6(TP53):c.857A>C (p.Glu286Ala)	TP53	E154A, E247A, E286A, E127A	Li-Fraumeni syndrome 1	VCV000376593	17	7577081	17	7673763	376593	363472	rs1057519985	NC_000017.11:7673762:T:G	single nucleotide variant	missense variant	Likely pathogenic	Feb 21, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.856G>A (p.Glu286Lys)	TP53	E154K, E247K, E286K, E127K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Spindle cell sarcoma|Medulloblastoma WNT activated|Neoplasm	VCV000183752	17	7577082	17	7673764	183752	185345	rs786201059	NC_000017.11:7673763:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 27, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Jun 5, 2025	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.854A>T (p.Glu285Val)	TP53	E285V, E153V, E246V, E126V	Li-Fraumeni syndrome|Neoplasm	VCV000012384	17	7577084	17	7673766	12384	27423	rs121912667	NC_000017.11:7673765:T:A	single nucleotide variant	missense variant	Pathogenic	Dec 21, 2018	criteria provided, single submitter				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.853G>A (p.Glu285Lys)	TP53	E153K, E246K, E285K, E126K	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenal cortex carcinoma|Neoplasm	VCV000420133	17	7577085	17	7673767	420133	410258	rs112431538	NC_000017.11:7673766:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 25, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Jul 2, 2025	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.851C>T (p.Thr284Ile)	TP53	T152I, T245I, T284I, T125I	Li-Fraumeni syndrome	VCV000216471	17	7577087	17	7673769	216471	213391	rs863224685	NC_000017.11:7673768:G:A	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.847C>T (p.Arg283Cys)	TP53	R151C, R244C, R283C, R124C	Li-Fraumeni syndrome	VCV000127824	17	7577091	17	7673773	127824	133281	rs149633775	NC_000017.11:7673772:G:A	single nucleotide variant	missense variant	Likely benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.845G>C (p.Arg282Pro)	TP53	R150P, R243P, R282P, R123P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Carcinoma of pancreas|Choroid plexus papilloma|Colorectal cancer|Bone osteosarcoma|Nasopharyngeal carcinoma|Adrenocortical carcinoma, hereditary|Bone marrow failure syndrome 5|Glioma susceptibility 1|Li-Fraumeni syndrome 1|Familial cancer of breast|Basal cell carcinoma, susceptibility to, 7|Hepatocellular carcinoma	VCV000376659	17	7577093	17	7673775	376659	363538	rs730882008	NC_000017.11:7673774:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.844C>G (p.Arg282Gly)	TP53	R150G, R243G, R282G, R123G	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000140821	17	7577094	17	7673776	140821	150535	rs28934574	NC_000017.11:7673775:G:C	single nucleotide variant	missense variant	Pathogenic	Sep 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.844C>T (p.Arg282Trp)	TP53	R282W, R150W, R243W, R123W	Astrocytoma, anaplastic|Pleomorphic xanthoastrocytoma|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Colorectal cancer|Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Medulloblastoma WNT activated|Melanoma|Signet ring cell carcinoma|Diffuse glioma, H3 G34 mutant|Diffuse midline glioma, H3 K27M-mutant|Astrocytoma IDH-mutant|Rhabdomyosarcoma|Neoplasm	VCV000012364	17	7577094	17	7673776	12364	27403	rs28934574	NC_000017.11:7673775:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 3, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Apr 4, 2025	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.843C>A (p.Asp281Glu)	TP53	D149E, D242E, D281E, D122E	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Malignant spindle cell neoplasm|Neoplasm	VCV000406568	17	7577095	17	7673777	406568	403007	rs1057519984	NC_000017.11:7673776:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 12, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Jan 4, 2024	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.842A>C (p.Asp281Ala)	TP53	D149A, D242A, D281A, D122A	Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Malignant glioma	VCV000376589	17	7577096	17	7673778	376589	363468	rs587781525	NC_000017.11:7673777:T:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 16, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Jun 3, 2025	criteria provided, single submitter				
NM_000546.6(TP53):c.842A>T (p.Asp281Val)	TP53	D149V, D242V, D281V, D122V	Adrenocortical carcinoma, hereditary|Bone osteosarcoma|Basal cell carcinoma, susceptibility to, 7|Familial pancreatic carcinoma|Familial cancer of breast|Hepatocellular carcinoma|Bone marrow failure syndrome 5|Li-Fraumeni syndrome 1|Nasopharyngeal carcinoma|Choroid plexus papilloma|Colorectal cancer|Glioma susceptibility 1|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000182968	17	7577096	17	7673778	182968	180995	rs587781525	NC_000017.11:7673777:T:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 2, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.842A>G (p.Asp281Gly)	TP53	D149G, D242G, D281G, D122G	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000141141	17	7577096	17	7673778	141141	150855	rs587781525	NC_000017.11:7673777:T:C	single nucleotide variant	missense variant	Pathogenic	Jul 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.841G>C (p.Asp281His)	TP53	D149H, D242H, D281H, D122H	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Rhabdomyosarcoma|Diffuse midline glioma, H3 K27M-mutant	VCV000376588	17	7577097	17	7673779	376588	363467	rs764146326	NC_000017.11:7673778:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 22, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Apr 11, 2025	criteria provided, single submitter				
NM_000546.6(TP53):c.841G>A (p.Asp281Asn)	TP53	D149N, D242N, D281N, D122N	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Neoplasm	VCV000376586	17	7577097	17	7673779	376586	363465	rs764146326	NC_000017.11:7673778:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 29, 2025	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.841G>T (p.Asp281Tyr)	TP53	D149Y, D242Y, D281Y, D122Y	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Medulloblastoma SHH activated and TP53 mutant|Neoplasm	VCV000376585	17	7577097	17	7673779	376585	363464	rs764146326	NC_000017.11:7673778:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 1, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Oct 22, 2024	criteria provided, single submitter	Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.840A>C (p.Arg280Ser)	TP53	R148S, R241S, R280S, R121S	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV000634747	17	7577098	17	7673780	634747	622585	rs1567547687	NC_000017.11:7673779:T:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.839G>C (p.Arg280Thr)	TP53	R280T, R148T, R241T, R121T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000012368	17	7577099	17	7673781	12368	27407	rs121912660	NC_000017.11:7673780:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 27, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.833C>T (p.Pro278Leu)	TP53	P146L, P239L, P278L, P119L	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000232497	17	7577105	17	7673787	232497	236459	rs876659802	NC_000017.11:7673786:G:A	single nucleotide variant	missense variant	Pathogenic	Aug 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.832C>A (p.Pro278Thr)	TP53	P146T, P239T, P278T, P119T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376643	17	7577106	17	7673788	376643	363522	rs17849781	NC_000017.11:7673787:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.832C>T (p.Pro278Ser)	TP53	P146S, P239S, P278S, P119S	not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Pleuropulmonary blastoma	VCV000376642	17	7577106	17	7673788	376642	363521	rs17849781	NC_000017.11:7673787:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Nov 9, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.829T>G (p.Cys277Gly)	TP53	C145G, C238G, C277G, C118G	Li-Fraumeni syndrome	VCV002757236	17	7577109	17	7673791	2757236	2921007	rs1064795369	NC_000017.11:7673790:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Dec 5, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.827C>G (p.Ala276Gly)	TP53	A144G, A237G, A276G, A117G	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000185319	17	7577111	17	7673793	185319	185349	rs786202082	NC_000017.11:7673792:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.825T>G (p.Cys275Trp)	TP53	C143W, C236W, C275W, C116W	Hereditary cancer-predisposing syndrome	VCV000485044	17	7577113	17	7673795	485044	479287	rs1555525279	NC_000017.11:7673794:A:C	single nucleotide variant	missense variant	Likely pathogenic	Jan 9, 2017	criteria provided, single submitter							
NM_000546.6(TP53):c.824G>T (p.Cys275Phe)	TP53	C143F, C236F, C275F, C116F	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Diffuse glioma, H3 G34 mutant|Neoplasm	VCV000376582	17	7577114	17	7673796	376582	363461	rs863224451	NC_000017.11:7673795:C:A	single nucleotide variant	missense variant	Pathogenic	Jul 30, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Oct 6, 2023	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.824G>A (p.Cys275Tyr)	TP53	C143Y, C236Y, C275Y, C116Y	Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000215997	17	7577114	17	7673796	215997	213392	rs863224451	NC_000017.11:7673795:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 7, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.820G>A (p.Val274Ile)	TP53	V142I, V115I, V235I, V274I	Hereditary cancer-predisposing syndrome	VCV003460325	17	7577118	17	7673800	3460325	3611136		NC_000017.11:7673799:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Oct 11, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.818G>T (p.Arg273Leu)	TP53	R141L, R234L, R273L, R114L	Adrenocortical carcinoma, hereditary|Glioma susceptibility 1|Bone osteosarcoma|Familial cancer of breast|Nasopharyngeal carcinoma|Li-Fraumeni syndrome 1|Basal cell carcinoma, susceptibility to, 7|Hepatocellular carcinoma|Carcinoma of pancreas|Choroid plexus papilloma|Colorectal cancer|Bone marrow failure syndrome 5|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Embryonal rhabdomyosarcoma|Neoplasm	VCV000376655	17	7577120	17	7673802	376655	363534	rs28934576	NC_000017.11:7673801:C:A	single nucleotide variant	missense variant	Pathogenic	Sep 29, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Mar 11, 2024	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.818G>C (p.Arg273Pro)	TP53	R141P, R234P, R273P, R114P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000231060	17	7577120	17	7673802	231060	236461	rs28934576	NC_000017.11:7673801:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 21, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.818G>A (p.Arg273His)	TP53	R273H, R141H, R234H, R114H	Li-Fraumeni syndrome|Diffuse midline glioma, H3 K27M-mutant|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Rhabdomyosarcoma|Ewing sarcoma|Neoplasm	VCV000012366	17	7577120	17	7673802	12366	27405	rs28934576	NC_000017.11:7673801:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	Tier I - Strong	Oct 31, 2025	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.817C>G (p.Arg273Gly)	TP53	R141G, R234G, R273G, R114G	Hereditary cancer-predisposing syndrome|Colorectal cancer|Bone marrow failure syndrome 5|Nasopharyngeal carcinoma|Bone osteosarcoma|Basal cell carcinoma, susceptibility to, 7|Li-Fraumeni syndrome 1|Carcinoma of pancreas|Choroid plexus papilloma|Hepatocellular carcinoma|Familial cancer of breast|Glioma susceptibility 1|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000634682	17	7577121	17	7673803	634682	622586	rs121913343	NC_000017.11:7673802:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 23, 2025	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.817C>A (p.Arg273Ser)	TP53	R141S, R234S, R273S, R114S	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376656	17	7577121	17	7673803	376656	363535	rs121913343	NC_000017.11:7673802:G:T	single nucleotide variant	missense variant	Pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.817C>T (p.Arg273Cys)	TP53	R141C, R234C, R273C, R114C	Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Diffuse midline glioma, H3 K27M-mutant|Medulloblastoma WNT activated|Primary intracranial sarcoma, DICER1-mutant|Adenocarcinoma of the large intestine|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Astrocytoma IDH-mutant|Embryonal rhabdomyosarcoma|Neoplasm	VCV000043594	17	7577121	17	7673803	43594	52763	rs121913343	NC_000017.11:7673802:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 16, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Jul 2, 2025	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.814G>C (p.Val272Leu)	TP53	V140L, V233L, V272L, V113L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000574679	17	7577124	17	7673806	574679	574631	rs121912657	NC_000017.11:7673805:C:G	single nucleotide variant	missense variant	Pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.814G>A (p.Val272Met)	TP53	V140M, V233M, V272M, V113M	Li-Fraumeni syndrome 1|Diffuse midline glioma, H3 K27M-mutant|Neoplasm	VCV000185814	17	7577124	17	7673806	185814	185350	rs121912657	NC_000017.11:7673805:C:T	single nucleotide variant	missense variant	Pathogenic	Mar 18, 2022	reviewed by expert panel	Tier I - Strong	Feb 16, 2024	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.814G>T (p.Val272Leu)	TP53	V272L, V140L, V233L, V113L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Pleomorphic xanthoastrocytoma|Neoplasm	VCV000012358	17	7577124	17	7673806	12358	27397	rs121912657	NC_000017.11:7673805:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts	Tier II - Potential	Mar 21, 2024	criteria provided, single submitter	Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.812A>T (p.Glu271Val)	TP53	E139V, E112V, E232V, E271V	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV003147994	17	7577126	17	7673808	3147994	3307242	rs2151016523	NC_000017.11:7673807:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 12, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.809T>G (p.Phe270Cys)	TP53	F138C, F231C, F270C, F111C	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary	VCV000376597	17	7577129	17	7673811	376597	363476	rs1057519986	NC_000017.11:7673810:A:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.809T>C (p.Phe270Ser)	TP53	F138S, F231S, F270S, F111S	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Neoplasm	VCV000376594	17	7577129	17	7673811	376594	363473	rs1057519986	NC_000017.11:7673810:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 13, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.808T>G (p.Phe270Val)	TP53	F138V, F231V, F270V, F111V	Hereditary cancer-predisposing syndrome|Choroid plexus carcinoma	VCV000376598	17	7577130	17	7673812	376598	363477	rs1057519988	NC_000017.11:7673811:A:C	single nucleotide variant	missense variant	Pathogenic	Jun 7, 2023	criteria provided, single submitter	Tier I - Strong	Jan 4, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.806G>T (p.Ser269Ile)	TP53	S110I, S137I, S230I, S269I	Acute myeloid leukemia	VCV002575169	17	7577132	17	7673814	2575169	2740099	rs2543545959	NC_000017.11:7673813:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic		no assertion criteria provided							
NM_000546.6(TP53):c.805A>T (p.Ser269Cys)	TP53	S110C, S137C, S230C, S269C	Acute myeloid leukemia	VCV002575177	17	7577133	17	7673815	2575177	2740107	rs1597362155	NC_000017.11:7673814:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Benign		no assertion criteria provided							
NM_000546.6(TP53):c.799C>G (p.Arg267Gly)	TP53	R228G, R267G, R108G, R135G	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Choroid plexus carcinoma	VCV001761541	17	7577139	17	7673821	1761541	1813848	rs55832599	NC_000017.11:7673820:G:C	single nucleotide variant	missense variant	Pathogenic	Jul 27, 2023	criteria provided, multiple submitters, no conflicts	Tier I - Strong	May 12, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.799C>T (p.Arg267Trp)	TP53	R135W, R228W, R267W, R108W	Breast and/or ovarian cancer|Li-Fraumeni syndrome 1|Hepatocellular carcinoma|Adrenocortical carcinoma, hereditary|Basal cell carcinoma, susceptibility to, 7|Familial cancer of breast|Glioma susceptibility 1|Bone osteosarcoma|Nasopharyngeal carcinoma|Carcinoma of pancreas|Choroid plexus papilloma|Carcinoma of colon|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Familial cancer of breast|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Familial cancer of breast|Medulloblastoma WNT activated|Neoplasm	VCV000141764	17	7577139	17	7673821	141764	151478	rs55832599	NC_000017.11:7673820:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 29, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Nov 15, 2022	criteria provided, single submitter	Likely oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.797G>A (p.Gly266Glu)	TP53	G134E, G227E, G266E, G107E	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Pleomorphic xanthoastrocytoma|Neoplasm	VCV000161516	17	7577141	17	7673823	161516	171614	rs193920774	NC_000017.11:7673822:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 28, 2024	criteria provided, multiple submitters, no conflicts	Tier II - Potential	Dec 12, 2023	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.796G>A (p.Gly266Arg)	TP53	G134R, G266R, G227R, G107R	Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000458566	17	7577142	17	7673824	458566	469137	rs1057519990	NC_000017.11:7673823:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 25, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.796G>C (p.Gly266Arg)	TP53	G134R, G227R, G266R, G107R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376605	17	7577142	17	7673824	376605	363484	rs1057519990	NC_000017.11:7673823:C:G	single nucleotide variant	missense variant	Pathogenic	Jun 18, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.794T>A (p.Leu265Gln)	TP53	L106Q, L226Q, L133Q, L265Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	VCV000953467	17	7577144	17	7673826	953467	950307	rs879253942	NC_000017.11:7673825:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 28, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.794T>C (p.Leu265Pro)	TP53	L133P, L226P, L265P, L106P	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000245777	17	7577144	17	7673826	245777	245069	rs879253942	NC_000017.11:7673825:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 20, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.788A>G (p.Asn263Ser)	TP53	N263S, N131S, N224S, N104S	Hereditary cancer-predisposing syndrome	VCV000827313	17	7577150	17	7673832	827313	814467	rs1597362411	NC_000017.11:7673831:T:C	single nucleotide variant	missense variant	Likely benign	Aug 29, 2019	criteria provided, single submitter							
NM_000546.6(TP53):c.784G>A (p.Gly262Ser)	TP53	G130S, G223S, G262S, G103S	Li-Fraumeni syndrome	VCV000141228	17	7577154	17	7673836	141228	150942	rs200579969	NC_000017.11:7673835:C:T	single nucleotide variant	missense variant	Likely benign	Apr 3, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.779C>A (p.Ser260Tyr)	TP53	S128Y, S221Y, S260Y, S101Y	Li-Fraumeni syndrome	VCV000231033	17	7577502	17	7674184	231033	236465	rs876658916	NC_000017.11:7674183:G:T	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.776A>C (p.Asp259Ala)	TP53	D100A, D127A, D220A, D259A	Malignant lymphoma, large B-cell, diffuse	VCV002671888	17	7577505	17	7674187	2671888	2839415	rs745425759	NC_000017.11:7674186:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Dec 4, 2023	no assertion criteria provided							
NM_000546.6(TP53):c.771_772delinsAA (p.Glu258Lys)	TP53	E126K, E219K, E258K, E99K	not provided	VCV004082532	17	7577509 - 7577510	17	7674191 - 7674192	4082532	4195218		NC_000017.11:7674190:CC:TT	Indel	missense variant|non-coding transcript variant	Likely pathogenic	May 21, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.772G>A (p.Glu258Lys)	TP53	E258K, E126K, E219K, E99K	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000012348	17	7577509	17	7674191	12348	27387	rs121912652	NC_000017.11:7674190:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 11, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.761_762delinsAT (p.Ile254Asn)	TP53	I215N, I254N, I122N, I95N	Li-Fraumeni syndrome	VCV002817584	17	7577519 - 7577520	17	7674201 - 7674202	2817584	2977395	rs2543558391	NC_000017.11:7674200:GA:AT	Indel	missense variant|non-coding transcript variant	Pathogenic	Nov 30, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.761T>C (p.Ile254Thr)	TP53	I215T, I122T, I254T, I95T	Li-Fraumeni syndrome	VCV001759844	17	7577520	17	7674202	1759844	1813445	rs1330865474	NC_000017.11:7674201:A:G	single nucleotide variant	missense variant	Pathogenic	Dec 5, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.761T>A (p.Ile254Asn)	TP53	I254N, I95N, I122N, I215N	Li-Fraumeni syndrome	VCV000856299	17	7577520	17	7674202	856299	846265	rs1330865474	NC_000017.11:7674201:A:T	single nucleotide variant	missense variant	Pathogenic	Dec 5, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.760A>G (p.Ile254Val)	TP53	I215V, I122V, I254V, I95V	Li-Fraumeni syndrome	VCV000406605	17	7577521	17	7674203	406605	402557	rs746601313	NC_000017.11:7674202:T:C	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.757A>G (p.Thr253Ala)	TP53	T214A, T253A, T94A, T121A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000827132	17	7577524	17	7674206	827132	814470	rs1597364185	NC_000017.11:7674205:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 26, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.751A>T (p.Ile251Phe)	TP53	I251F, I92F, I119F, I212F	Li-Fraumeni syndrome|Adrenal cortex carcinoma	VCV001518844	17	7577530	17	7674212	1518844	1343038	rs730882007	NC_000017.11:7674211:T:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 8, 2023	criteria provided, single submitter	Tier I - Strong	Oct 10, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.751A>C (p.Ile251Leu)	TP53	I119L, I212L, I251L, I92L	Gastric cancer|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1	VCV000182937	17	7577530	17	7674212	182937	180998	rs730882007	NC_000017.11:7674211:T:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 20, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.749C>T (p.Pro250Leu)	TP53	P118L, P211L, P250L, P91L	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Neoplasm	VCV000420136	17	7577532	17	7674214	420136	410263	rs1064794311	NC_000017.11:7674213:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 22, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.747G>T (p.Arg249Ser)	TP53	R249S, R117S, R210S, R90S	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Neoplasm	VCV000012352	17	7577534	17	7674216	12352	27391	rs28934571	NC_000017.11:7674215:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 14, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.746G>C (p.Arg249Thr)	TP53	R117T, R210T, R249T, R90T	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided	VCV000376015	17	7577535	17	7674217	376015	362894	rs587782329	NC_000017.11:7674216:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.743G>C (p.Arg248Pro)	TP53	R116P, R209P, R248P, R89P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000237954	17	7577538	17	7674220	237954	242980	rs11540652	NC_000017.11:7674219:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.743G>T (p.Arg248Leu)	TP53	R116L, R209L, R248L, R89L	Li-Fraumeni syndrome|Neoplasm	VCV000230253	17	7577538	17	7674220	230253	236469	rs11540652	NC_000017.11:7674219:C:A	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel				Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.743G>A (p.Arg248Gln)	TP53	R248Q, R116Q, R209Q, R89Q	Li-Fraumeni syndrome|Embryonal tumor with multilayered rosettes|Adenocarcinoma of the large intestine|Medulloblastoma WNT activated|Diffuse midline glioma, H3 K27M-mutant|Nasopharyngeal carcinoma|Embryonal rhabdomyosarcoma|Neoplasm	VCV000012356	17	7577538	17	7674220	12356	27395	rs11540652	NC_000017.11:7674219:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	Tier I - Strong	Dec 17, 2024	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.741_742delinsTT (p.Arg248Trp)	TP53	R209W, R89W, R116W, R248W	Li-Fraumeni syndrome	VCV000437017	17	7577539 - 7577540	17	7674221 - 7674222	437017	430018	rs1555525498	NC_000017.11:7674220:GG:AA	Indel	missense variant	Likely pathogenic	Mar 31, 2017	criteria provided, single submitter							
NM_000546.6(TP53):c.742C>G (p.Arg248Gly)	TP53	R116G, R209G, R248G, R89G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Carcinoma of colon|Neoplasm	VCV000376652	17	7577539	17	7674221	376652	363531	rs121912651	NC_000017.11:7674220:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.742C>T (p.Arg248Trp)	TP53	R248W, R116W, R209W, R89W	Li-Fraumeni syndrome|Breast phyllodes tumor|Diffuse glioma, H3 G34 mutant|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Medulloblastoma SHH activated and TP53 mutant|Neoplasm	VCV000012347	17	7577539	17	7674221	12347	27386	rs121912651	NC_000017.11:7674220:G:A	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	Tier I - Strong	Oct 20, 2025	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.738G>C (p.Met246Ile)	TP53	M87I, M207I, M246I, M114I	Hereditary cancer-predisposing syndrome	VCV001758655	17	7577543	17	7674225	1758655	1819366	rs1019340046	NC_000017.11:7674224:C:G	single nucleotide variant	missense variant	Likely pathogenic	Dec 12, 2017	criteria provided, single submitter							
NM_000546.6(TP53):c.738G>A (p.Met246Ile)	TP53	M246I, M114I, M207I, M87I	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome|Neoplasm	VCV000480961	17	7577543	17	7674225	480961	479328	rs1019340046	NC_000017.11:7674224:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 19, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.737T>A (p.Met246Lys)	TP53	M114K, M246K, M207K, M87K	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000480764	17	7577544	17	7674226	480764	479245	rs587780074	NC_000017.11:7674225:A:T	single nucleotide variant	missense variant	Likely pathogenic	Sep 21, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.736A>G (p.Met246Val)	TP53	M114V, M207V, M246V, M87V	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000100815	17	7577545	17	7674227	100815	106675	rs483352695	NC_000017.11:7674226:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 3, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.734_735delinsAT (p.Gly245Asp)	TP53	G206D, G113D, G245D, G86D	Li-Fraumeni syndrome	VCV000861760	17	7577546 - 7577547	17	7674228 - 7674229	861760	846267	rs2073251813	NC_000017.11:7674227:GC:AT	Indel	missense variant	Pathogenic	Apr 1, 2019	criteria provided, single submitter							
NM_000546.6(TP53):c.734G>T (p.Gly245Val)	TP53	G113V, G206V, G245V, G86V	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Neoplasm	VCV000376603	17	7577547	17	7674229	376603	363482	rs121912656	NC_000017.11:7674228:C:A	single nucleotide variant	missense variant	Pathogenic	Nov 15, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.734G>A (p.Gly245Asp)	TP53	G245D, G113D, G206D, G86D	Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Diffuse midline glioma, H3 K27M-mutant|Astrocytoma IDH-mutant|Embryonal rhabdomyosarcoma	VCV000012355	17	7577547	17	7674229	12355	27394	rs121912656	NC_000017.11:7674228:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 1, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Oct 2, 2024	criteria provided, single submitter				
NM_000546.6(TP53):c.733G>A (p.Gly245Ser)	TP53	G245S, G113S, G206S, G86S	Li-Fraumeni syndrome|Medulloblastoma WNT activated|IDH-wildtype glioblastoma|Rhabdomyosarcoma|Neoplasm	VCV000012365	17	7577548	17	7674230	12365	27404	rs28934575	NC_000017.11:7674229:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	Tier I - Strong	Sep 11, 2024	criteria provided, single submitter	Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.733G>T (p.Gly245Cys)	TP53	G245C, G113C, G206C, G86C	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Ovarian mucinous adenocarcinoma|Neoplasm	VCV000012349	17	7577548	17	7674230	12349	27388	rs28934575	NC_000017.11:7674229:C:A	single nucleotide variant	missense variant	Pathogenic	Mar 14, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Mar 17, 2025	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.731G>C (p.Gly244Ala)	TP53	G112A, G205A, G244A, G85A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000458560	17	7577550	17	7674232	458560	467518	rs985033810	NC_000017.11:7674231:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 2, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.731G>T (p.Gly244Val)	TP53	G112V, G205V, G244V, G85V	Li-Fraumeni syndrome 1	VCV000376601	17	7577550	17	7674232	376601	363480	rs985033810	NC_000017.11:7674231:C:A	single nucleotide variant	missense variant	Likely pathogenic	Feb 16, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.731G>A (p.Gly244Asp)	TP53	G112D, G205D, G244D, G85D	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Neoplasm	VCV000372785	17	7577550	17	7674232	372785	360335	rs985033810	NC_000017.11:7674231:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.730G>A (p.Gly244Ser)	TP53	G112S, G205S, G244S, G85S	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Diffuse midline glioma, H3 K27M-mutant|Neoplasm	VCV000376600	17	7577551	17	7674233	376600	363479	rs1057519989	NC_000017.11:7674232:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 15, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Oct 8, 2024	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.726C>G (p.Cys242Trp)	TP53	C110W, C203W, C242W, C83W	Li-Fraumeni syndrome	VCV000376580	17	7577555	17	7674237	376580	363459	rs375874539	NC_000017.11:7674236:G:C	single nucleotide variant	missense variant	Pathogenic	Mar 9, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.725G>A (p.Cys242Tyr)	TP53	C242Y, C110Y, C203Y, C83Y	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Familial cancer of breast	VCV000012354	17	7577556	17	7674238	12354	27393	rs121912655	NC_000017.11:7674237:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 17, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.722C>A (p.Ser241Tyr)	TP53	S109Y, S202Y, S241Y, S82Y	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000376663	17	7577559	17	7674241	376663	363542	rs28934573	NC_000017.11:7674240:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 29, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.722C>G (p.Ser241Cys)	TP53	S109C, S202C, S241C, S82C	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000177791	17	7577559	17	7674241	177791	176503	rs28934573	NC_000017.11:7674240:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 23, 2025	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.722C>T (p.Ser241Phe)	TP53	S241F, S109F, S202F, S82F	Hepatocellular carcinoma|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Glioma susceptibility 1|Bone marrow failure syndrome 5|Bone osteosarcoma|Basal cell carcinoma, susceptibility to, 7|Carcinoma of pancreas|Choroid plexus papilloma|Nasopharyngeal carcinoma|Familial cancer of breast|Colorectal cancer|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Medulloblastoma WNT activated|Diffuse midline glioma, H3 K27M-mutant|Spindle cell sarcoma|Neoplasm	VCV000012359	17	7577559	17	7674241	12359	27398	rs28934573	NC_000017.11:7674240:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 18, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Jun 5, 2025	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.721T>A (p.Ser241Thr)	TP53	S109T, S202T, S241T, S82T	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Embryonal rhabdomyosarcoma|Diffuse midline glioma, H3 K27M-mutant	VCV000959232	17	7577560	17	7674242	959232	950308	rs1057520002	NC_000017.11:7674241:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 18, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Jun 16, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.721T>G (p.Ser241Ala)	TP53	S109A, S202A, S241A, S82A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376665	17	7577560	17	7674242	376665	363544	rs1057520002	NC_000017.11:7674241:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.719G>A (p.Ser240Asn)	TP53	S108N, S201N, S240N, S81N	Acute myeloid leukemia	VCV002502882	17	7577562	17	7674244	2502882	2667997	rs2073256828	NC_000017.11:7674243:C:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic		no assertion criteria provided							
NM_000546.6(TP53):c.718A>T (p.Ser240Cys)	TP53	S108C, S201C, S240C, S81C	Hereditary cancer-predisposing syndrome	VCV003972460	17	7577563	17	7674245	3972460	4089472		NC_000017.11:7674244:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 10, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.718A>G (p.Ser240Gly)	TP53	S201G, S240G, S108G, S81G	TP53-related disorder|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck	VCV000584921	17	7577563	17	7674245	584921	576031	rs1567549584	NC_000017.11:7674244:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 24, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.717C>A (p.Asn239Lys)	TP53	N80K, N200K, N107K, N239K	Hereditary cancer-predisposing syndrome	VCV004189258	17	7577564	17	7674246	4189258	4304828		NC_000017.11:7674245:G:T	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Sep 5, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.716A>G (p.Asn239Ser)	TP53	N107S, N200S, N239S, N80S	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376637	17	7577565	17	7674247	376637	363516	rs1057519999	NC_000017.11:7674246:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 15, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.714T>G (p.Cys238Trp)	TP53	C106W, C199W, C238W, C79W	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000161515	17	7577567	17	7674249	161515	171615	rs193920789	NC_000017.11:7674248:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 28, 2020	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.713G>C (p.Cys238Ser)	TP53	C106S, C199S, C238S, C79S	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376575	17	7577568	17	7674250	376575	363454	rs730882005	NC_000017.11:7674249:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 13, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.713G>T (p.Cys238Phe)	TP53	C106F, C199F, C238F, C79F	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376574	17	7577568	17	7674250	376574	363453	rs730882005	NC_000017.11:7674249:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 4, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.713G>A (p.Cys238Tyr)	TP53	C106Y, C199Y, C238Y, C79Y	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000182935	17	7577568	17	7674250	182935	181000	rs730882005	NC_000017.11:7674249:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 30, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.712T>G (p.Cys238Gly)	TP53	C106G, C199G, C238G, C79G	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376577	17	7577569	17	7674251	376577	363456	rs1057519981	NC_000017.11:7674250:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 12, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.712T>C (p.Cys238Arg)	TP53	C106R, C199R, C238R, C79R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376576	17	7577569	17	7674251	376576	363455	rs1057519981	NC_000017.11:7674250:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 9, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.711G>C (p.Met237Ile)	TP53	M105I, M198I, M237I, M78I	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	VCV001757269	17	7577570	17	7674252	1757269	1819274	rs587782664	NC_000017.11:7674251:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.711G>T (p.Met237Ile)	TP53	M105I, M198I, M237I, M78I	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Medulloblastoma SHH activated and TP53 mutant|Primary intracranial sarcoma, DICER1-mutant	VCV000634770	17	7577570	17	7674252	634770	622595	rs587782664	NC_000017.11:7674251:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 22, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Oct 3, 2024	criteria provided, single submitter				
NM_000546.6(TP53):c.711G>A (p.Met237Ile)	TP53	M105I, M198I, M237I, M78I	Li-Fraumeni syndrome 1|Clear cell sarcoma|Neoplasm	VCV000142714	17	7577570	17	7674252	142714	152428	rs587782664	NC_000017.11:7674251:C:T	single nucleotide variant	missense variant	Pathogenic	Apr 20, 2021	reviewed by expert panel	Tier II - Potential	May 21, 2025	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.710T>A (p.Met237Lys)	TP53	M105K, M198K, M237K, M78K	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000376636	17	7577571	17	7674253	376636	363515	rs765848205	NC_000017.11:7674252:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 16, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.706T>C (p.Tyr236His)	TP53	Y104H, Y197H, Y236H, Y77H	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000216469	17	7577575	17	7674257	216469	213394	rs587782289	NC_000017.11:7674256:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 25, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.704A>G (p.Asn235Ser)	TP53	N103S, N196S, N235S, N76S	Li-Fraumeni syndrome	VCV000127821	17	7577577	17	7674259	127821	133278	rs144340710	NC_000017.11:7674258:T:C	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.701A>G (p.Tyr234Cys)	TP53	Y102C, Y195C, Y234C, Y75C	not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm	VCV000127820	17	7577580	17	7674262	127820	133277	rs587780073	NC_000017.11:7674261:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 25, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.700T>A (p.Tyr234Asn)	TP53	Y102N, Y195N, Y234N, Y75N	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000376692	17	7577581	17	7674263	376692	363571	rs864622237	NC_000017.11:7674262:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 26, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.700T>C (p.Tyr234His)	TP53	Y102H, Y195H, Y234H, Y75H	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Neoplasm	VCV000376691	17	7577581	17	7674263	376691	363570	rs864622237	NC_000017.11:7674262:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 30, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.700T>G (p.Tyr234Asp)	TP53	Y102D, Y195D, Y234D, Y75D	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000219759	17	7577581	17	7674263	219759	222738	rs864622237	NC_000017.11:7674262:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.695T>A (p.Ile232Asn)	TP53	I232N, I193N, I73N, I100N	Li-Fraumeni syndrome|Colorectal cancer	VCV000850008	17	7577586	17	7674268	850008	846269	rs587781589	NC_000017.11:7674267:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 23, 2021	criteria provided, multiple submitters, no conflicts	Tier II - Potential	Oct 10, 2024	no assertion criteria provided				
NM_000546.6(TP53):c.695T>G (p.Ile232Ser)	TP53	I100S, I193S, I232S, I73S	Hereditary cancer-predisposing syndrome	VCV000634756	17	7577586	17	7674268	634756	622596	rs587781589	NC_000017.11:7674267:A:C	single nucleotide variant	missense variant	Pathogenic	Mar 28, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.695T>C (p.Ile232Thr)	TP53	I100T, I193T, I232T, I73T	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	VCV000141224	17	7577586	17	7674268	141224	150938	rs587781589	NC_000017.11:7674267:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.682G>T (p.Asp228Tyr)	TP53	D228Y, D96Y, D189Y, D69Y	Hereditary cancer-predisposing syndrome	VCV002450759	17	7577599	17	7674281	2450759	2423245	rs2151022353	NC_000017.11:7674280:C:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Mar 2, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.659A>G (p.Tyr220Cys)	TP53	Y181C, Y220C, Y88C, Y61C	Li-Fraumeni syndrome|Adenocarcinoma of the large intestine|Ovarian mucinous adenocarcinoma|Diffuse midline glioma, H3 K27M-mutant|Embryonal rhabdomyosarcoma|Astrocytoma IDH-mutant|Neoplasm	VCV000127819	17	7578190	17	7674872	127819	133276	rs121912666	NC_000017.11:7674871:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	Tier I - Strong	Jan 15, 2025	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.659A>C (p.Tyr220Ser)	TP53	Y220S, Y181S, Y88S, Y61S	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Undifferentiated embryonal sarcoma of the liver	VCV000012383	17	7578190	17	7674872	12383	27422	rs121912666	NC_000017.11:7674871:T:G	single nucleotide variant	missense variant	Pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Mar 23, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.658T>C (p.Tyr220His)	TP53	Y181H, Y220H, Y88H, Y61H	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome	VCV000376687	17	7578191	17	7674873	376687	363566	rs530941076	NC_000017.11:7674872:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.653T>A (p.Val218Glu)	TP53	V179E, V218E, V86E, V59E	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Neoplasm	VCV001754112	17	7578196	17	7674878	1754112	1804667	rs1555525743	NC_000017.11:7674877:A:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 15, 2025	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.646G>A (p.Val216Met)	TP53	V177M, V216M, V84M, V57M	not provided|Adrenocortical carcinoma, hereditary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000182965	17	7578203	17	7674885	182965	181005	rs730882025	NC_000017.11:7674884:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 10, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.641A>T (p.His214Leu)	TP53	H175L, H214L, H82L, H55L	Li-Fraumeni syndrome	VCV000376616	17	7578208	17	7674890	376616	363495	rs1057519992	NC_000017.11:7674889:T:A	single nucleotide variant	missense variant	Likely pathogenic	May 7, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.641A>G (p.His214Arg)	TP53	H175R, H214R, H82R, H55R	Li-Fraumeni syndrome|Neoplasm	VCV000376615	17	7578208	17	7674890	376615	363494	rs1057519992	NC_000017.11:7674889:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.637_639delinsTGG (p.Arg213Trp)	TP53	R174W, R54W, R81W, R213W	Hereditary cancer-predisposing syndrome	VCV003460335	17	7578210 - 7578212	17	7674892 - 7674894	3460335	3611146		NC_000017.11:7674891:TCG:CCA	Indel	missense variant	Likely pathogenic	Nov 19, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.638G>C (p.Arg213Pro)	TP53	R174P, R213P, R81P, R54P	Hereditary cancer-predisposing syndrome|not specified|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000231214	17	7578211	17	7674893	231214	236477	rs587778720	NC_000017.11:7674892:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 17, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.638G>A (p.Arg213Gln)	TP53	R174Q, R213Q, R81Q, R54Q	Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenal cortex carcinoma|Embryonal rhabdomyosarcoma|Neoplasm	VCV000135359	17	7578211	17	7674893	135359	139098	rs587778720	NC_000017.11:7674892:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 18, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	May 19, 2025	criteria provided, single submitter	Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.635T>C (p.Phe212Ser)	TP53	F53S, F212S, F173S, F80S	Hereditary cancer-predisposing syndrome	VCV003460339	17	7578214	17	7674896	3460339	3611150		NC_000017.11:7674895:A:G	single nucleotide variant	missense variant	Likely benign	Nov 26, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.629A>G (p.Asn210Ser)	TP53	N171S, N210S, N51S, N78S	Hereditary cancer-predisposing syndrome	VCV003232058	17	7578220	17	7674902	3232058	3385598	rs2151026881	NC_000017.11:7674901:T:C	single nucleotide variant	missense variant	Likely benign	Dec 21, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.622G>A (p.Asp208Asn)	TP53	D49N, D169N, D76N, D208N	Hereditary cancer-predisposing syndrome	VCV001752332	17	7578227	17	7674909	1752332	1804187	rs1597368376	NC_000017.11:7674908:C:T	single nucleotide variant	missense variant	Likely benign	Apr 15, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.621T>G (p.Asp207Glu)	TP53	D207E, D48E, D75E, D168E	Hereditary cancer-predisposing syndrome	VCV003809687	17	7578228	17	7674910	3809687	3928226		NC_000017.11:7674909:A:C	single nucleotide variant	missense variant	Likely benign	Mar 7, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.614A>G (p.Tyr205Cys)	TP53	Y166C, Y205C, Y73C, Y46C	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376681	17	7578235	17	7674917	376681	363560	rs1057520007	NC_000017.11:7674916:T:C	single nucleotide variant	missense variant	Pathogenic	Jan 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.613T>G (p.Tyr205Asp)	TP53	Y166D, Y205D, Y73D, Y46D	not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376686	17	7578236	17	7674918	376686	363565	rs1057520008	NC_000017.11:7674917:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jan 28, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.613T>C (p.Tyr205His)	TP53	Y166H, Y205H, Y73H, Y46H	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000376685	17	7578236	17	7674918	376685	363564	rs1057520008	NC_000017.11:7674917:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 15, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.612G>C (p.Glu204Asp)	TP53	E72D, E204D, E165D, E45D	Hereditary cancer-predisposing syndrome	VCV003460304	17	7578237	17	7674919	3460304	3611115		NC_000017.11:7674918:C:G	single nucleotide variant	missense variant	Likely benign	Jul 16, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.596G>T (p.Gly199Val)	TP53	G160V, G199V, G67V, G40V	not provided|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype	VCV000451799	17	7578253	17	7674935	451799	445903	rs1555525857	NC_000017.11:7674934:C:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 20, 2018	criteria provided, single submitter	Tier I - Strong	Nov 7, 2022	criteria provided, single submitter				
NM_000546.6(TP53):c.589G>A (p.Val197Met)	TP53	V158M, V197M, V65M, V38M	Li-Fraumeni syndrome|Neoplasm	VCV000188060	17	7578260	17	7674942	188060	186277	rs786204041	NC_000017.11:7674941:C:T	single nucleotide variant	missense variant	Likely pathogenic	Dec 5, 2025	reviewed by expert panel				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.587G>C (p.Arg196Pro)	TP53	R157P, R196P, R64P, R37P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000231165	17	7578262	17	7674944	231165	236479	rs483352697	NC_000017.11:7674943:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 2, 2024	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.584T>C (p.Ile195Thr)	TP53	I156T, I195T, I63T, I36T	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Li-Fraumeni syndrome 1|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Astrocytoma IDH-mutant|Neoplasm	VCV000216077	17	7578265	17	7674947	216077	213398	rs760043106	NC_000017.11:7674946:A:G	single nucleotide variant	missense variant	Pathogenic	Jan 10, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Jun 23, 2023	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.580C>T (p.Leu194Phe)	TP53	L155F, L194F, L62F, L35F	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000127817	17	7578269	17	7674951	127817	133274	rs587780071	NC_000017.11:7674950:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Aug 21, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.578A>C (p.His193Pro)	TP53	H154P, H193P, H61P, H34P	Li-Fraumeni syndrome	VCV000376612	17	7578271	17	7674953	376612	363491	rs786201838	NC_000017.11:7674952:T:G	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.578A>G (p.His193Arg)	TP53	H154R, H193R, H61R, H34R	Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Diffuse midline glioma, H3 K27M-mutant	VCV000184979	17	7578271	17	7674953	184979	185367	rs786201838	NC_000017.11:7674952:T:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 14, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Jul 26, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.577C>A (p.His193Asn)	TP53	H154N, H193N, H61N, H34N	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV003460301	17	7578272	17	7674954	3460301	363493	rs876658468	NC_000017.11:7674953:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.577C>T (p.His193Tyr)	TP53	H154Y, H193Y, H61Y, H34Y	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000230256	17	7578272	17	7674954	230256	236481	rs876658468	NC_000017.11:7674953:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 11, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.576G>C (p.Gln192His)	TP53	Q153H, Q192H, Q33H, Q60H	Malignant tumor of esophagus	VCV000988617	17	7578273	17	7674955	988617	976548	rs2073344721	NC_000017.11:7674954:C:G	single nucleotide variant	missense variant	Likely benign		criteria provided, single submitter							
NM_000546.6(TP53):c.572C>G (p.Pro191Arg)	TP53	P152R, P191R, P59R, P32R	Li-Fraumeni syndrome	VCV000127816	17	7578277	17	7674959	127816	133273	rs587778718	NC_000017.11:7674958:G:C	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.569C>T (p.Pro190Leu)	TP53	P151L, P190L, P58L, P31L	Li-Fraumeni syndrome 1	VCV000418517	17	7578280	17	7674962	418517	410268	rs876660825	NC_000017.11:7674961:G:A	single nucleotide variant	missense variant	Likely pathogenic	Jun 27, 2022	reviewed by expert panel							
NM_000546.6(TP53):c.558T>A (p.Asp186Glu)	TP53	D147E, D186E, D54E, D27E	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000230006	17	7578372	17	7675054	230006	236484	rs375275361	NC_000017.11:7675053:A:T	single nucleotide variant	missense variant	Likely benign	Nov 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.556G>A (p.Asp186Asn)	TP53	D54N, D147N, D186N, D27N	Li-Fraumeni syndrome	VCV000406601	17	7578374	17	7675056	406601	402562	rs1060501206	NC_000017.11:7675055:C:T	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.555C>G (p.Ser185Arg)	TP53	S53R, S146R, S26R, S185R	Hereditary cancer-predisposing syndrome	VCV001748280	17	7578375	17	7675057	1748280	1806528	rs367560109	NC_000017.11:7675056:G:C	single nucleotide variant	missense variant	Likely benign	Nov 1, 2021	criteria provided, single submitter							
NM_000546.6(TP53):c.554G>A (p.Ser185Asn)	TP53	S146N, S185N, S53N, S26N	Li-Fraumeni syndrome	VCV000141359	17	7578376	17	7675058	141359	151073	rs150607408	NC_000017.11:7675057:C:T	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.547T>C (p.Ser183Pro)	TP53	S144P, S24P, S51P, S183P	Hereditary cancer-predisposing syndrome	VCV003328150	17	7578383	17	7675065	3328150	3486863		NC_000017.11:7675064:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	May 8, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.542G>C (p.Arg181Pro)	TP53	R181P, R22P, R142P, R49P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Embryonal rhabdomyosarcoma	VCV000825729	17	7578388	17	7675070	825729	814487	rs397514495	NC_000017.11:7675069:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Nov 22, 2022	criteria provided, single submitter				
NM_000546.6(TP53):c.542G>A (p.Arg181His)	TP53	R142H, R181H, R49H, R22H	Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck	VCV000142320	17	7578388	17	7675070	142320	152034	rs397514495	NC_000017.11:7675069:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Dec 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.541C>T (p.Arg181Cys)	TP53	R142C, R181C, R49C, R22C	Li-Fraumeni syndrome|Colorectal cancer|Neoplasm	VCV000142624	17	7578389	17	7675071	142624	152338	rs587782596	NC_000017.11:7675070:G:A	single nucleotide variant	missense variant	Likely pathogenic	Dec 5, 2025	reviewed by expert panel	Tier I - Strong	Oct 17, 2023	criteria provided, single submitter	Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.538G>A (p.Glu180Lys)	TP53	E141K, E180K, E48K, E21K	Li-Fraumeni syndrome	VCV000245711	17	7578392	17	7675074	245711	245073	rs879253911	NC_000017.11:7675073:C:T	single nucleotide variant	missense variant	Likely pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.537T>A (p.His179Gln)	TP53	H140Q, H47Q, H179Q, H20Q	Li-Fraumeni syndrome	VCV000406578	17	7578393	17	7675075	406578	402563	rs876660821	NC_000017.11:7675074:A:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.537T>G (p.His179Gln)	TP53	H140Q, H179Q, H47Q, H20Q	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000376607	17	7578393	17	7675075	376607	363486	rs876660821	NC_000017.11:7675074:A:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 7, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.535C>G (p.His179Asp)	TP53	H140D, H179D, H47D, H20D	Adrenocortical carcinoma, hereditary|not provided|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Diffuse glioma, H3 G34 mutant	VCV000376610	17	7578395	17	7675077	376610	363489	rs587780070	NC_000017.11:7675076:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Mar 29, 2024	criteria provided, single submitter				
NM_000546.6(TP53):c.535C>T (p.His179Tyr)	TP53	H140Y, H179Y, H47Y, H20Y	Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Diffuse midline glioma, H3 K27M-mutant|Primary intracranial sarcoma, DICER1-mutant|Neoplasm	VCV000127815	17	7578395	17	7675077	127815	133272	rs587780070	NC_000017.11:7675076:G:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Mar 18, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Jan 5, 2023	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.534C>G (p.His178Gln)	TP53	H178Q, H46Q, H19Q, H139Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000947223	17	7578396	17	7675078	947223	928554	rs1555526001	NC_000017.11:7675077:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 13, 2023	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.534C>A (p.His178Gln)	TP53	H46Q, H139Q, H178Q, H19Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Hereditary breast ovarian cancer syndrome	VCV000575702	17	7578396	17	7675078	575702	569777	rs1555526001	NC_000017.11:7675077:G:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Nov 7, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.532C>G (p.His178Asp)	TP53	H178D, H46D, H139D, H19D	Li-Fraumeni syndrome	VCV000482223	17	7578398	17	7675080	482223	480057	rs1064795203	NC_000017.11:7675079:G:C	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.530C>G (p.Pro177Arg)	TP53	P177R, P45R, P138R, P18R	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	VCV000458547	17	7578400	17	7675082	458547	468390	rs751477326	NC_000017.11:7675081:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 24, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.526_528delinsCGG (p.Cys176Arg)	TP53	C17R, C44R, C137R, C176R	Ovarian neoplasm	VCV000634759	17	7578402 - 7578404	17	7675084 - 7675086	634759	622616	rs1567552847	NC_000017.11:7675083:GCA:CCG	Indel	missense variant	Likely pathogenic	Dec 1, 2018	no assertion criteria provided							
NM_000546.6(TP53):c.527G>T (p.Cys176Phe)	TP53	C137F, C176F, C44F, C17F	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Diffuse midline glioma, H3 K27M-mutant|Ewing sarcoma|Embryonal rhabdomyosarcoma|Alveolar rhabdomyosarcoma|Neoplasm	VCV000376569	17	7578403	17	7675085	376569	363448	rs786202962	NC_000017.11:7675084:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 30, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	May 14, 2025	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.527G>A (p.Cys176Tyr)	TP53	C137Y, C176Y, C44Y, C17Y	Squamous cell carcinoma|TP53-related disorder|Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000186451	17	7578403	17	7675085	186451	185371	rs786202962	NC_000017.11:7675084:C:T	single nucleotide variant	missense variant	Pathogenic	Dec 30, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.524G>T (p.Arg175Leu)	TP53	R136L, R175L, R43L, R16L	Li-Fraumeni syndrome	VCV000182963	17	7578406	17	7675088	182963	181010	rs28934578	NC_000017.11:7675087:C:A	single nucleotide variant	missense variant	Likely pathogenic	Sep 6, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.524G>A (p.Arg175His)	TP53	R175H, R136H, R43H, R16H	Li-Fraumeni syndrome|Medulloblastoma SHH activated and TP53 mutant|Undifferentiated embryonal sarcoma of the liver|Small intestine adenocarcinoma|IDH-wildtype glioblastoma|Diffuse midline glioma, H3 K27M-mutant|Astrocytoma IDH-mutant|Neoplasm	VCV000012374	17	7578406	17	7675088	12374	27413	rs28934578	NC_000017.11:7675087:C:T	single nucleotide variant	missense variant	Pathogenic	Sep 6, 2024	reviewed by expert panel	Tier I - Strong	Aug 20, 2025	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.523C>G (p.Arg175Gly)	TP53	R136G, R175G, R43G, R16G	Li-Fraumeni syndrome|Neoplasm	VCV000376649	17	7578407	17	7675089	376649	363528	rs138729528	NC_000017.11:7675088:G:C	single nucleotide variant	missense variant	Pathogenic	Sep 6, 2024	reviewed by expert panel				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.521G>A (p.Arg174Lys)	TP53	R135K, R174K, R42K, R15K	not provided|not specified	VCV000423887	17	7578409	17	7675091	423887	410272	rs1064796681	NC_000017.11:7675090:C:T	single nucleotide variant	missense variant	Likely benign	Dec 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.518T>C (p.Val173Ala)	TP53	V134A, V173A, V41A, V14A	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Astrocytoma IDH-mutant|Neoplasm	VCV000376017	17	7578412	17	7675094	376017	362896	rs1057519747	NC_000017.11:7675093:A:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	May 15, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Oct 22, 2023	criteria provided, single submitter	Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.517G>T (p.Val173Leu)	TP53	V134L, V173L, V41L, V14L	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000376668	17	7578413	17	7675095	376668	363547	rs876660754	NC_000017.11:7675094:C:A	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 16, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.517G>A (p.Val173Met)	TP53	V134M, V173M, V41M, V14M	Li-Fraumeni syndrome|Neoplasm	VCV000233951	17	7578413	17	7675095	233951	232035	rs876660754	NC_000017.11:7675094:C:T	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel				Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.513G>T (p.Glu171Asp)	TP53	E12D, E132D, E171D, E39D	Acute myeloid leukemia	VCV002446885	17	7578417	17	7675099	2446885	2422010	rs1555526078	NC_000017.11:7675098:C:A	single nucleotide variant	non-coding transcript variant|missense variant	Pathogenic		no assertion criteria provided							
NM_000546.6(TP53):c.512A>G (p.Glu171Gly)	TP53	E132G, E171G, E39G, E12G	Hereditary cancer-predisposing syndrome	VCV001745525	17	7578418	17	7675100	1745525	1802577	rs2543596753	NC_000017.11:7675099:T:C	single nucleotide variant	missense variant	Pathogenic	Jan 24, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.511G>A (p.Glu171Lys)	TP53	E132K, E171K, E39K, E12K	Li-Fraumeni syndrome	VCV000141566	17	7578419	17	7675101	141566	151280	rs587781845	NC_000017.11:7675100:C:T	single nucleotide variant	missense variant	Likely benign	Mar 4, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.509C>T (p.Thr170Met)	TP53	T131M, T170M, T38M, T11M	Li-Fraumeni syndrome	VCV000184014	17	7578421	17	7675103	184014	185374	rs779000871	NC_000017.11:7675102:G:A	single nucleotide variant	missense variant	Likely benign	Feb 7, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.503A>C (p.His168Pro)	TP53	H129P, H36P, H168P, H9P	Hereditary cancer-predisposing syndrome|Embryonal tumor with multilayered rosettes	VCV003328154	17	7578427	17	7675109	3328154	3486867		NC_000017.11:7675108:T:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Jun 14, 2024	criteria provided, single submitter	Tier I - Strong	Sep 8, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.503A>T (p.His168Leu)	TP53	H129L, H168L, H36L, H9L	Hereditary cancer-predisposing syndrome|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype	VCV001744933	17	7578427	17	7675109	1744933	1805779	rs867114783	NC_000017.11:7675108:T:A	single nucleotide variant	missense variant	Pathogenic	Dec 3, 2020	criteria provided, single submitter	Tier I - Strong	Dec 4, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.496T>A (p.Ser166Thr)	TP53	S127T, S34T, S166T, S7T	Hereditary cancer-predisposing syndrome	VCV003809673	17	7578434	17	7675116	3809673	3928212		NC_000017.11:7675115:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Dec 12, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.494A>T (p.Gln165Leu)	TP53	Q126L, Q165L, Q33L, Q6L	Acute myeloid leukemia	VCV002505496	17	7578436	17	7675118	2505496	2670460	rs2151031435	NC_000017.11:7675117:T:A	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic		no assertion criteria provided							
NM_000546.6(TP53):c.490A>G (p.Lys164Glu)	TP53	K125E, K164E, K32E, K5E	Li-Fraumeni syndrome	VCV000246416	17	7578440	17	7675122	246416	245075	rs879254249	NC_000017.11:7675121:T:C	single nucleotide variant	missense variant	Pathogenic	Jun 5, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.488A>G (p.Tyr163Cys)	TP53	Y124C, Y163C, Y31C, Y4C	Li-Fraumeni syndrome|Diffuse midline glioma, H3 K27M-mutant|Neoplasm	VCV000127814	17	7578442	17	7675124	127814	133271	rs148924904	NC_000017.11:7675123:T:C	single nucleotide variant	missense variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	Tier I - Strong	Apr 13, 2023	criteria provided, single submitter	Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.487T>C (p.Tyr163His)	TP53	Y124H, Y163H, Y31H, Y4H	Li-Fraumeni syndrome	VCV000376680	17	7578443	17	7675125	376680	363559	rs786203436	NC_000017.11:7675124:A:G	single nucleotide variant	missense variant	Pathogenic	Dec 5, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.481G>A (p.Ala161Thr)	TP53	A122T, A161T, A29T, A2T	Hereditary cancer-predisposing syndrome|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000161518	17	7578449	17	7675131	161518	171616	rs193920817	NC_000017.11:7675130:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 9, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.480G>A (p.Met160Ile)	TP53	M121I, M160I, M28I, M1I	Li-Fraumeni syndrome	VCV000230758	17	7578450	17	7675132	230758	236488	rs772354334	NC_000017.11:7675131:C:T	single nucleotide variant	missense variant|initiator_codon_variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.476C>A (p.Ala159Asp)	TP53	A120D, A159D, A27D	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Diffuse midline glioma, H3 K27M-mutant	VCV001026335	17	7578454	17	7675136	1026335	1013159	rs1555526131	NC_000017.11:7675135:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Nov 9, 2022	criteria provided, single submitter				
NM_000546.6(TP53):c.476C>T (p.Ala159Val)	TP53	A120V, A159V, A27V	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Embryonal rhabdomyosarcoma|Neoplasm	VCV000458545	17	7578454	17	7675136	458545	467544	rs1555526131	NC_000017.11:7675135:G:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Apr 28, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Jul 6, 2023	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.473_474delinsTT (p.Arg158Leu)	TP53	R158L, R119L, R26L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000568285	17	7578456 - 7578457	17	7675138 - 7675139	568285	574635	rs1567553501	NC_000017.11:7675137:GC:AA	Indel	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jul 8, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.473G>T (p.Arg158Leu)	TP53	R158L, R26L, R119L	Li-Fraumeni syndrome|Diffuse midline glioma, H3 K27M-mutant	VCV000528248	17	7578457	17	7675139	528248	531819	rs587782144	NC_000017.11:7675138:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Dec 5, 2025	reviewed by expert panel	Tier I - Strong	Apr 12, 2024	criteria provided, single submitter				
NM_000546.6(TP53):c.473G>C (p.Arg158Pro)	TP53	R119P, R158P, R26P	Li-Fraumeni syndrome|IDH-wildtype glioblastoma|Neoplasm	VCV000246118	17	7578457	17	7675139	246118	245076	rs587782144	NC_000017.11:7675138:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Dec 5, 2025	reviewed by expert panel	Tier I - Strong	Oct 14, 2025	criteria provided, single submitter	Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.473G>A (p.Arg158His)	TP53	R119H, R158H, R26H	Li-Fraumeni syndrome 1|Familial pancreatic carcinoma|Hepatocellular carcinoma|Adrenocortical carcinoma, hereditary|Basal cell carcinoma, susceptibility to, 7|Colorectal cancer|Familial cancer of breast|Glioma susceptibility 1|Bone osteosarcoma|Nasopharyngeal carcinoma|Bone marrow failure syndrome 5|Choroid plexus papilloma|Hereditary cancer-predisposing syndrome|Breast and/or ovarian cancer|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Neoplasm	VCV000141963	17	7578457	17	7675139	141963	151677	rs587782144	NC_000017.11:7675138:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Mar 27, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.472C>A (p.Arg158Ser)	TP53	R119S, R158S, R26S	Li-Fraumeni syndrome|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype	VCV001067910	17	7578458	17	7675140	1067910	1056473	rs587780068	NC_000017.11:7675139:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Sep 13, 2023	criteria provided, single submitter	Tier I - Strong	Dec 17, 2024	criteria provided, single submitter				
NM_000546.6(TP53):c.472C>G (p.Arg158Gly)	TP53	R158G, R26G, R119G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Diffuse glioma, H3 G34 mutant|Malignant glioma	VCV000856171	17	7578458	17	7675140	856171	846283	rs587780068	NC_000017.11:7675139:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Mar 31, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Oct 31, 2025	criteria provided, single submitter				
NM_000546.6(TP53):c.470_471delinsGT (p.Val157Gly)	TP53	V25G, V157G, V118G	Li-Fraumeni syndrome 1	VCV003148383	17	7578459 - 7578460	17	7675141 - 7675142	3148383	3307631	rs2543600379	NC_000017.11:7675140:GA:AC	Indel	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Feb 14, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.470T>G (p.Val157Gly)	TP53	V118G, V157G, V25G	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Diffuse midline glioma, H3 K27M-mutant	VCV000915695	17	7578460	17	7675142	915695	904019	rs1131691023	NC_000017.11:7675141:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 14, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Dec 20, 2022	criteria provided, single submitter				
NM_000546.6(TP53):c.469G>A (p.Val157Ile)	TP53	V118I, V157I, V25I	Li-Fraumeni syndrome	VCV000185404	17	7578461	17	7675143	185404	185377	rs121912654	NC_000017.11:7675142:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.469G>T (p.Val157Phe)	TP53	V157F, V118F, V25F	Squamous cell carcinoma|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000012353	17	7578461	17	7675143	12353	27392	rs121912654	NC_000017.11:7675142:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.467G>C (p.Arg156Pro)	TP53	R117P, R156P, R24P	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Diffuse midline glioma, H3 K27M-mutant	VCV000634768	17	7578463	17	7675145	634768	622620	rs371524413	NC_000017.11:7675144:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 29, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Nov 28, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.464C>A (p.Thr155Asn)	TP53	T155N, T116N, T23N	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Malignant peripheral nerve sheath tumor	VCV000406564	17	7578466	17	7675148	406564	402565	rs786202752	NC_000017.11:7675147:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jul 17, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Oct 5, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.455C>G (p.Pro152Arg)	TP53	P152R, P20R, P113R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neuroblastoma	VCV000824998	17	7578475	17	7675157	824998	814494	rs587782705	NC_000017.11:7675156:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Mar 13, 2024	criteria provided, multiple submitters, no conflicts	Tier II - Potential	Apr 11, 2023	criteria provided, single submitter				
NM_000546.6(TP53):c.455C>T (p.Pro152Leu)	TP53	P113L, P152L, P20L	Li-Fraumeni syndrome|Diffuse glioma, H3 G34 mutant|Neoplasm	VCV000142766	17	7578475	17	7675157	142766	152480	rs587782705	NC_000017.11:7675156:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Aug 5, 2024	reviewed by expert panel	Tier I - Strong	Apr 1, 2024	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.451_452delinsAG (p.Pro151Ser)	TP53	P151S, P19S, P112S	Li-Fraumeni syndrome	VCV002700111	17	7578478 - 7578479	17	7675160 - 7675161	2700111	2858963	rs1597370899	NC_000017.11:7675159:GG:CT	Indel	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic	Jun 11, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.451_452delinsTT (p.Pro151Phe)	TP53	P151F, P19F, P112F	Hereditary cancer-predisposing syndrome	VCV000824960	17	7578478 - 7578479	17	7675160 - 7675161	824960	814495	rs1597370899	NC_000017.11:7675159:GG:AA	Indel	missense variant|5 prime UTR variant	Likely pathogenic	Oct 4, 2019	criteria provided, single submitter							
NM_000546.6(TP53):c.452C>G (p.Pro151Arg)	TP53	P112R, P151R, P19R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376640	17	7578478	17	7675160	376640	363519	rs1057520000	NC_000017.11:7675159:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 15, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.451C>G (p.Pro151Ala)	TP53	P112A, P151A, P19A	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000376641	17	7578479	17	7675161	376641	363520	rs28934874	NC_000017.11:7675160:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Oct 10, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.451C>T (p.Pro151Ser)	TP53	P151S, P112S, P19S	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype	VCV000012370	17	7578479	17	7675161	12370	27409	rs28934874	NC_000017.11:7675160:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jun 17, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Feb 11, 2025	criteria provided, single submitter				
NM_000546.6(TP53):c.451C>A (p.Pro151Thr)	TP53	P151T, P112T, P19T	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary	VCV000012369	17	7578479	17	7675161	12369	27408	rs28934874	NC_000017.11:7675160:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Mar 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.440T>G (p.Val147Gly)	TP53	V108G, V147G, V15G	Li-Fraumeni syndrome	VCV003602769	17	7578490	17	7675172	3602769	3735483		NC_000017.11:7675171:A:C	single nucleotide variant	missense variant|non-coding transcript variant|5 prime UTR variant	Likely pathogenic	Feb 4, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.428T>C (p.Val143Ala)	TP53	V104A, V11A, V143A	Li-Fraumeni syndrome	VCV000804214	17	7578502	17	7675184	804214	792574	rs1555526241	NC_000017.11:7675183:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.427G>A (p.Val143Met)	TP53	V104M, V11M, V143M	Glioma susceptibility 1|Familial pancreatic carcinoma|Hepatocellular carcinoma|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Colorectal cancer|Familial cancer of breast|Nasopharyngeal carcinoma|Choroid plexus papilloma|Bone marrow failure syndrome 5|Bone osteosarcoma|Basal cell carcinoma, susceptibility to, 7|Hereditary cancer-predisposing syndrome|Breast neoplasm|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000142657	17	7578503	17	7675185	142657	152371	rs587782620	NC_000017.11:7675184:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 17, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.423C>G (p.Cys141Trp)	TP53	C102W, C141W, C9W	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Diffuse midline glioma, H3 K27M-mutant	VCV000376564	17	7578507	17	7675189	376564	363443	rs1057519977	NC_000017.11:7675188:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jul 6, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Aug 14, 2024	criteria provided, single submitter				
NM_000546.6(TP53):c.422G>A (p.Cys141Tyr)	TP53	C102Y, C141Y, C9Y	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000140801	17	7578508	17	7675190	140801	150515	rs587781288	NC_000017.11:7675189:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Nov 22, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.413C>T (p.Ala138Val)	TP53	A138V, A6V, A99V	Li-Fraumeni syndrome|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Choroid plexus carcinoma|Neoplasm	VCV000184863	17	7578517	17	7675199	184863	185387	rs750600586	NC_000017.11:7675198:G:A	single nucleotide variant	5 prime UTR variant|missense variant	Likely pathogenic	Jun 5, 2025	reviewed by expert panel	Tier I - Strong	Feb 5, 2024	criteria provided, single submitter	Likely oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.412G>C (p.Ala138Pro)	TP53	A138P, A6P, A99P	Li-Fraumeni syndrome	VCV000012376	17	7578518	17	7675200	12376	27415	rs28934875	NC_000017.11:7675199:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jun 5, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.404G>C (p.Cys135Ser)	TP53	C135S, C3S, C96S	not provided	VCV003893309	17	7578526	17	7675208	3893309	4009190		NC_000017.11:7675207:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Oct 23, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.404G>T (p.Cys135Phe)	TP53	C135F, C3F, C96F	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Pleuropulmonary blastoma|Embryonal rhabdomyosarcoma	VCV000376559	17	7578526	17	7675208	376559	363438	rs587781991	NC_000017.11:7675207:C:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	May 31, 2024	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Jun 7, 2024	criteria provided, single submitter				
NM_000546.6(TP53):c.403T>G (p.Cys135Gly)	TP53	C135G, C3G, C96G	Li-Fraumeni syndrome	VCV000376563	17	7578527	17	7675209	376563	363442	rs1057519975	NC_000017.11:7675208:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.403T>C (p.Cys135Arg)	TP53	C135R, C3R, C96R	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000376560	17	7578527	17	7675209	376560	363439	rs1057519975	NC_000017.11:7675208:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.401T>G (p.Phe134Cys)	TP53	F134C, F2C, F95C	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000230477	17	7578529	17	7675211	230477	236493	rs780442292	NC_000017.11:7675210:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely pathogenic	Jan 31, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.400T>A (p.Phe134Ile)	TP53	F95I, F134I, F2I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV000480953	17	7578530	17	7675212	480953	479343	rs267605077	NC_000017.11:7675211:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.398T>C (p.Met133Thr)	TP53	M133T, M1T, M94T	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000012357	17	7578532	17	7675214	12357	27396	rs28934873	NC_000017.11:7675213:A:G	single nucleotide variant	missense variant|initiator_codon_variant|5 prime UTR variant	Pathogenic	Oct 26, 2023	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.396G>T (p.Lys132Asn)	TP53	K132N, K93N	not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000634773	17	7578534	17	7675216	634773	622631	rs866775781	NC_000017.11:7675215:C:A	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Pathogenic/Likely pathogenic	Aug 5, 2024	criteria provided, multiple submitters, no conflicts				Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.396G>C (p.Lys132Asn)	TP53	K132N, K93N	Li-Fraumeni syndrome|Choroid plexus carcinoma|Neoplasm	VCV000376624	17	7578534	17	7675216	376624	363503	rs866775781	NC_000017.11:7675215:C:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Mar 18, 2022	reviewed by expert panel	Tier I - Strong	Mar 9, 2025	criteria provided, single submitter	Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.395A>G (p.Lys132Arg)	TP53	K132R, K93R	Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary|Choroid plexus papilloma|Colorectal cancer|Bone osteosarcoma|Nasopharyngeal carcinoma|Adrenocortical carcinoma, hereditary|Bone marrow failure syndrome 5|Glioma susceptibility 1|Li-Fraumeni syndrome 1|Familial cancer of breast|Basal cell carcinoma, susceptibility to, 7|Familial pancreatic carcinoma|Hepatocellular carcinoma|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000376625	17	7578535	17	7675217	376625	363504	rs1057519996	NC_000017.11:7675216:T:C	single nucleotide variant	missense variant|non-coding transcript variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Sep 10, 2025	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.392A>T (p.Asn131Ile)	TP53	N131I, N92I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000428902	17	7578538	17	7675220	428902	420665	rs1131691037	NC_000017.11:7675219:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Feb 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.391A>C (p.Asn131His)	TP53	N131H, N92H	Breast-ovarian cancer, familial, susceptibility to, 1	VCV004279056	17	7578539	17	7675221	4279056	4391604		NC_000017.11:7675220:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely pathogenic	Jul 30, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.391A>T (p.Asn131Tyr)	TP53	N131Y, N92Y	Hereditary cancer-predisposing syndrome|Neoplasm	VCV000141988	17	7578539	17	7675221	141988	151702	rs587782160	NC_000017.11:7675220:T:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Mar 5, 2024	criteria provided, single submitter				Likely oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.389T>A (p.Leu130His)	TP53	L130H, L91H	Hereditary cancer-predisposing syndrome	VCV000824351	17	7578541	17	7675223	824351	814500	rs1131691013	NC_000017.11:7675222:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Aug 7, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.389T>C (p.Leu130Pro)	TP53	L130P, L91P	Adrenocortical carcinoma, hereditary|Glioma susceptibility 1|Bone osteosarcoma|Familial cancer of breast|Nasopharyngeal carcinoma|Li-Fraumeni syndrome 1|Basal cell carcinoma, susceptibility to, 7|Hepatocellular carcinoma|Carcinoma of pancreas|Choroid plexus papilloma|Colorectal cancer|Bone marrow failure syndrome 5|Hereditary cancer-predisposing syndrome	VCV000428873	17	7578541	17	7675223	428873	420666	rs1131691013	NC_000017.11:7675222:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	May 13, 2022	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.386C>A (p.Ala129Asp)	TP53	A129D, A90D	Hereditary cancer-predisposing syndrome	VCV001735669	17	7578544	17	7675226	1735669	1790163	rs137852792	NC_000017.11:7675225:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Benign	Nov 10, 2021	criteria provided, single submitter							
NM_000546.6(TP53):c.380C>A (p.Ser127Tyr)	TP53	S127Y, S88Y	Li-Fraumeni syndrome 1	VCV000656751	17	7578550	17	7675232	656751	646767	rs730881999	NC_000017.11:7675231:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Apr 20, 2021	reviewed by expert panel							
NM_000546.6(TP53):c.380C>G (p.Ser127Cys)	TP53	S127C, S88C	Li-Fraumeni syndrome	VCV000219532	17	7578550	17	7675232	219532	222742	rs730881999	NC_000017.11:7675231:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic	Jul 14, 2023	criteria provided, single submitter							
NM_000546.6(TP53):c.380C>T (p.Ser127Phe)	TP53	S127F, S88F	Hereditary cancer-predisposing syndrome|not specified|not provided|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Diffuse midline glioma, H3 K27M-mutant|Neoplasm	VCV000182928	17	7578550	17	7675232	182928	181015	rs730881999	NC_000017.11:7675231:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jun 30, 2025	criteria provided, multiple submitters, no conflicts	Tier I - Strong	Dec 12, 2023	criteria provided, single submitter	Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.379T>C (p.Ser127Pro)	TP53	S127P, S88P	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000934410	17	7578551	17	7675233	934410	938240	rs1597371694	NC_000017.11:7675232:A:G	single nucleotide variant	missense variant|5 prime UTR variant	Pathogenic/Likely pathogenic	Jan 9, 2025	criteria provided, multiple submitters, no conflicts				Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.374C>G (p.Thr125Arg)	TP53	T125R, T86R	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Neoplasm	VCV000376667	17	7579313	17	7675995	376667	363546	rs786201057	NC_000017.11:7675994:G:C	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Apr 29, 2025	criteria provided, multiple submitters, no conflicts				Likely oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.374C>A (p.Thr125Lys)	TP53	T125K, T86K	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV000216465	17	7579313	17	7675995	216465	213402	rs786201057	NC_000017.11:7675994:G:T	single nucleotide variant	missense variant	Pathogenic	Nov 13, 2024	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.372C>G (p.Cys124Trp)	TP53	C124W, C85W	Hereditary cancer-predisposing syndrome	VCV003809674	17	7579315	17	7675997	3809674	3928213		NC_000017.11:7675996:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jan 27, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.370T>C (p.Cys124Arg)	TP53	C124R, C85R	Li-Fraumeni syndrome	VCV004056245	17	7579317	17	7675999	4056245	4170183		NC_000017.11:7675998:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Feb 29, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.370T>A (p.Cys124Ser)	TP53	C124S, C85S	Li-Fraumeni syndrome	VCV000182926	17	7579317	17	7675999	182926	181018	rs730881997	NC_000017.11:7675998:A:T	single nucleotide variant	missense variant	Likely benign	Feb 6, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.364G>A (p.Val122Met)	TP53	V122M, V83M	Li-Fraumeni syndrome	VCV000141101	17	7579323	17	7676005	141101	150815	rs587781495	NC_000017.11:7676004:C:T	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.353C>T (p.Thr118Ile)	TP53	T118I, T79I	Li-Fraumeni syndrome	VCV000419837	17	7579334	17	7676016	419837	410278	rs1064794141	NC_000017.11:7676015:G:A	single nucleotide variant	missense variant	Likely benign	Mar 4, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.344A>G (p.His115Arg)	TP53	H115R, H76R	Li-Fraumeni syndrome	VCV000182925	17	7579343	17	7676025	182925	181019	rs730881996	NC_000017.11:7676024:T:C	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.339C>G (p.Phe113Leu)	TP53	F113L, F74L	Li-Fraumeni syndrome	VCV002702402	17	7579348	17	7676030	2702402	2856119	rs2151038938	NC_000017.11:7676029:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 20, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.339C>A (p.Phe113Leu)	TP53	F113L, F74L	Li-Fraumeni syndrome	VCV002125367	17	7579348	17	7676030	2125367	2177968	rs2151038938	NC_000017.11:7676029:G:T	single nucleotide variant	missense variant	Likely pathogenic	Jul 7, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.338T>G (p.Phe113Cys)	TP53	F113C, F74C	Li-Fraumeni syndrome	VCV000634690	17	7579349	17	7676031	634690	622637	rs1567555667	NC_000017.11:7676030:A:C	single nucleotide variant	missense variant	Pathogenic	Dec 16, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.337T>C (p.Phe113Leu)	TP53	F113L, F74L	Li-Fraumeni syndrome	VCV003634432	17	7579350	17	7676032	3634432	3763655		NC_000017.11:7676031:A:G	single nucleotide variant	missense variant|non-coding transcript variant	Pathogenic	Aug 20, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.337T>A (p.Phe113Ile)	TP53	F74I, F113I	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	VCV001469551	17	7579350	17	7676032	1469551	1475500	rs587781642	NC_000017.11:7676031:A:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Jun 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.332T>A (p.Leu111Gln)	TP53	L111Q, L72Q	Li-Fraumeni syndrome	VCV000376632	17	7579355	17	7676037	376632	363511	rs1057519997	NC_000017.11:7676036:A:T	single nucleotide variant	missense variant	Pathogenic	Jun 5, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.332T>G (p.Leu111Arg)	TP53	L111R, L72R	Li-Fraumeni syndrome	VCV000376631	17	7579355	17	7676037	376631	363510	rs1057519997	NC_000017.11:7676036:A:C	single nucleotide variant	missense variant	Likely pathogenic	Dec 5, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.332T>C (p.Leu111Pro)	TP53	L111P, L72P	Li-Fraumeni syndrome	VCV000376630	17	7579355	17	7676037	376630	363509	rs1057519997	NC_000017.11:7676036:A:G	single nucleotide variant	missense variant	Pathogenic	Dec 5, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.329_330delinsCC (p.Arg110Pro)	TP53	R110P, R71P	Li-Fraumeni syndrome	VCV000641505	17	7579357 - 7579358	17	7676039 - 7676040	641505	646770	rs1597373700	NC_000017.11:7676038:AC:GG	Indel	missense variant	Pathogenic	Apr 1, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.329G>T (p.Arg110Leu)	TP53	R110L, R71L	Li-Fraumeni syndrome|Adenocarcinoma of the large intestine|Neoplasm	VCV000406597	17	7579358	17	7676040	406597	402569	rs11540654	NC_000017.11:7676039:C:A	single nucleotide variant	missense variant	Pathogenic	Jun 5, 2025	reviewed by expert panel	Tier I - Strong	Oct 16, 2023	criteria provided, single submitter	Oncogenic	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.329G>C (p.Arg110Pro)	TP53	R110P, R71P	Li-Fraumeni syndrome|Astrocytoma, IDH-mutant, grade 3|IDH-wildtype glioblastoma|Neoplasm	VCV000233627	17	7579358	17	7676040	233627	236497	rs11540654	NC_000017.11:7676039:C:G	single nucleotide variant	missense variant	Pathogenic	Jun 5, 2025	reviewed by expert panel	Tier I - Strong	Mar 6, 2025	criteria provided, single submitter	Oncogenic	Dec 29, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.329G>A (p.Arg110His)	TP53	R110H, R71H	Li-Fraumeni syndrome	VCV000127808	17	7579358	17	7676040	127808	133265	rs11540654	NC_000017.11:7676039:C:T	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.328C>G (p.Arg110Gly)	TP53	R71G, R110G	Li-Fraumeni syndrome	VCV000823452	17	7579359	17	7676041	823452	814506	rs587781371	NC_000017.11:7676040:G:C	single nucleotide variant	missense variant	Likely pathogenic	Jun 5, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.326T>G (p.Phe109Cys)	TP53	F109C, F70C	Li-Fraumeni syndrome 1	VCV000634784	17	7579361	17	7676043	634784	622638	rs1064796722	NC_000017.11:7676042:A:C	single nucleotide variant	missense variant	Likely pathogenic	Feb 12, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.325T>A (p.Phe109Ile)	TP53	F109I, F70I	Li-Fraumeni syndrome|not provided	VCV002627017	17	7579362	17	7676044	2627017	2794537	rs1057523496	NC_000017.11:7676043:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely pathogenic	Dec 29, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.322G>A (p.Gly108Ser)	TP53	G108S, G69S	Li-Fraumeni syndrome	VCV000142431	17	7579365	17	7676047	142431	152145	rs587782461	NC_000017.11:7676046:C:T	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.5(TP53):c.319T>C (p.Tyr107His)	TP53	Y107H, Y68H	Li-Fraumeni syndrome	VCV000140786	17	7579368	17	7676050	140786	150500	rs368771578	NC_000017.11:7676049:A:G	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.318C>G (p.Ser106Arg)	TP53	S106R, S67R	Li-Fraumeni syndrome	VCV000492752	17	7579369	17	7676051	492752	485679	rs1555526581	NC_000017.11:7676050:G:C	single nucleotide variant	missense variant	Pathogenic	Dec 5, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.313G>A (p.Gly105Ser)	TP53	G105S, G66S	Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Adrenocortical carcinoma, hereditary	VCV000428884	17	7579374	17	7676056	428884	420671	rs1060501195	NC_000017.11:7676055:C:T	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Sep 10, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.313G>C (p.Gly105Arg)	TP53	G66R, G105R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1	VCV000406574	17	7579374	17	7676056	406574	402601	rs1060501195	NC_000017.11:7676055:C:G	single nucleotide variant	missense variant	Pathogenic/Likely pathogenic	Oct 4, 2023	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.283T>A (p.Ser95Thr)	TP53	S95T, S56T	Hereditary cancer-predisposing syndrome	VCV004189261	17	7579404	17	7676086	4189261	4304831		NC_000017.11:7676085:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jun 23, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.281C>T (p.Ser94Leu)	TP53	S55L, S94L	Hereditary cancer-predisposing syndrome	VCV001796426	17	7579406	17	7676088	1796426	1852861	rs2151040269	NC_000017.11:7676087:G:A	single nucleotide variant	missense variant	Likely benign	Sep 25, 2020	criteria provided, single submitter							
NM_000546.6(TP53):c.280T>G (p.Ser94Ala)	TP53	S94A, S55A	Hereditary cancer-predisposing syndrome	VCV003460308	17	7579407	17	7676089	3460308	3611119		NC_000017.11:7676088:A:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jul 23, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.250G>A (p.Ala84Thr)	TP53	A45T, A84T	Li-Fraumeni syndrome	VCV000140833	17	7579437	17	7676119	140833	150547	rs587781307	NC_000017.11:7676118:C:T	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.247G>C (p.Ala83Pro)	TP53	A83P, A44P	Hereditary cancer-predisposing syndrome	VCV003972448	17	7579440	17	7676122	3972448	4089460		NC_000017.11:7676121:C:G	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Apr 25, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.245C>T (p.Pro82Leu)	TP53	P43L, P82L	Li-Fraumeni syndrome	VCV000182946	17	7579442	17	7676124	182946	181024	rs534447939	NC_000017.11:7676123:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.236C>T (p.Ala79Val)	TP53	A79V, A40V	Hereditary cancer-predisposing syndrome	VCV004189271	17	7579451	17	7676133	4189271	4304841		NC_000017.11:7676132:G:A	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Aug 4, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.227C>G (p.Ala76Gly)	TP53	A37G, A76G	Hereditary cancer-predisposing syndrome	VCV003460333	17	7579460	17	7676142	3460333	3611144		NC_000017.11:7676141:G:C	single nucleotide variant	missense variant|non-coding transcript variant	Benign	Nov 11, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.221C>T (p.Ala74Val)	TP53	A35V, A74V	Li-Fraumeni syndrome	VCV000141547	17	7579466	17	7676148	141547	151261	rs587781832	NC_000017.11:7676147:G:A	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.215_219delinsGCGTA (p.Pro72Arg)	TP53	P33R, P72R	Li-Fraumeni syndrome 1	VCV004071424	17	7579468 - 7579472	17	7676150 - 7676154	4071424	4185271		NC_000017.11:7676149:CACGG:TACGC	Indel	missense variant|non-coding transcript variant	Benign	Apr 1, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.218T>A (p.Val73Glu)	TP53	V34E, V73E	Hereditary cancer-predisposing syndrome	VCV003460312	17	7579469	17	7676151	3460312	3611123		NC_000017.11:7676150:A:T	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Sep 4, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.217G>A (p.Val73Met)	TP53	V34M, V73M	Li-Fraumeni syndrome	VCV000142386	17	7579470	17	7676152	142386	152100	rs587782423	NC_000017.11:7676151:C:T	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.215_216delinsGA (p.Pro72Arg)	TP53	P33R, P72R	Hereditary cancer-predisposing syndrome	VCV003809677	17	7579471 - 7579472	17	7676153 - 7676154	3809677	3928216		NC_000017.11:7676152:GG:TC	Indel	missense variant|non-coding transcript variant	Benign	Dec 19, 2024	criteria provided, single submitter							
NM_000546.6(TP53):c.215_216inv (p.Pro72Arg)	TP53	P33R, P72R	Li-Fraumeni syndrome	VCV003728507	17	7579471 - 7579472	17	7676153 - 7676154	3728507	3851838		NC_000017.11:7676152:GG:CC	Inversion	missense variant|non-coding transcript variant	Likely benign	Jan 6, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.215_216delinsGT (p.Pro72Arg)	TP53	P33R, P72R	Hereditary cancer-predisposing syndrome|not specified|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	VCV000237944	17	7579471 - 7579472	17	7676153 - 7676154	237944	242989	rs878854066	NC_000017.11:7676152:GG:AC	Indel	missense variant	Benign/Likely benign	May 27, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.213_215delinsTCG (p.Pro72Arg)	TP53	P33R, P72R	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	VCV003460311	17	7579472 - 7579474	17	7676154 - 7676156	3460311	3611122		NC_000017.11:7676153:GGG:CGA	Indel	missense variant|non-coding transcript variant	Benign	Apr 1, 2025	criteria provided, multiple submitters, no conflicts							
NM_000546.6(TP53):c.215C>A (p.Pro72His)	TP53	P33H, P72H	Li-Fraumeni syndrome	VCV000185120	17	7579472	17	7676154	185120	185405	rs1042522	NC_000017.11:7676153:G:T	single nucleotide variant	missense variant	Benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.215C>G (p.Pro72Arg)	TP53	P72R, P33R	Li-Fraumeni syndrome|Neoplasm	VCV000012351	17	7579472	17	7676154	12351	27390	rs1042522	NC_000017.11:7676153:G:C	single nucleotide variant	missense variant	Benign	Dec 5, 2025	reviewed by expert panel				Benign	Mar 4, 2025	criteria provided, single submitter	
NM_000546.6(TP53):c.214C>G (p.Pro72Ala)	TP53	P33A, P72A	Li-Fraumeni syndrome	VCV000142854	17	7579473	17	7676155	142854	152568	rs587782769	NC_000017.11:7676154:G:C	single nucleotide variant	missense variant	Likely benign	Feb 6, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.196A>G (p.Met66Val)	TP53	M66V, M27V	Hereditary cancer-predisposing syndrome	VCV001783578	17	7579491	17	7676173	1783578	1839674	rs2073477248	NC_000017.11:7676172:T:C	single nucleotide variant	missense variant	Likely benign	Oct 15, 2021	criteria provided, single submitter							
NM_000546.6(TP53):c.188C>G (p.Ala63Gly)	TP53	A24G, A63G	Li-Fraumeni syndrome	VCV000229693	17	7579499	17	7676181	229693	236509	rs372201428	NC_000017.11:7676180:G:C	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.188C>T (p.Ala63Val)	TP53	A24V, A63V	Li-Fraumeni syndrome	VCV000182922	17	7579499	17	7676181	182922	181027	rs372201428	NC_000017.11:7676180:G:A	single nucleotide variant	missense variant	Benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.187G>A (p.Ala63Thr)	TP53	A24T, A63T	Hereditary cancer-predisposing syndrome	VCV000231015	17	7579500	17	7676182	231015	236510	rs876658902	NC_000017.11:7676181:C:T	single nucleotide variant	missense variant	Likely benign	Mar 16, 2021	criteria provided, single submitter							
NM_000546.6(TP53):c.185A>G (p.Glu62Gly)	TP53	E23G, E62G	Hereditary cancer-predisposing syndrome	VCV003809683	17	7579502	17	7676184	3809683	3928222		NC_000017.11:7676183:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Feb 10, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.176G>A (p.Gly59Asp)	TP53	G20D, G59D	Hereditary cancer-predisposing syndrome	VCV000820048	17	7579511	17	7676193	820048	814517	rs1597374828	NC_000017.11:7676192:C:T	single nucleotide variant	missense variant	Likely benign	Jan 21, 2021	criteria provided, single submitter							
NM_000546.6(TP53):c.172C>G (p.Pro58Ala)	TP53	P19A, P58A	Hereditary cancer-predisposing syndrome	VCV001778944	17	7579515	17	7676197	1778944	1831528	rs2073479616	NC_000017.11:7676196:G:C	single nucleotide variant	missense variant	Likely benign	Feb 10, 2021	criteria provided, single submitter							
NM_000546.6(TP53):c.170A>T (p.Asp57Val)	TP53	D18V, D57V	Hereditary cancer-predisposing syndrome	VCV001778520	17	7579517	17	7676199	1778520	1834492	rs1442824382	NC_000017.11:7676198:T:A	single nucleotide variant	missense variant	Likely benign	Nov 10, 2021	criteria provided, single submitter							
NM_000546.6(TP53):c.149T>C (p.Ile50Thr)	TP53	I11T, I50T	Li-Fraumeni syndrome	VCV000216464	17	7579538	17	7676220	216464	213405	rs370502517	NC_000017.11:7676219:A:G	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.145G>A (p.Asp49Asn)	TP53	D10N, D49N	Li-Fraumeni syndrome	VCV000186363	17	7579542	17	7676224	186363	185412	rs587780728	NC_000017.11:7676223:C:T	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.145G>C (p.Asp49His)	TP53	D10H, D49H	Li-Fraumeni syndrome	VCV000135948	17	7579542	17	7676224	135948	139660	rs587780728	NC_000017.11:7676223:C:G	single nucleotide variant	missense variant	Benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.144C>A (p.Asp48Glu)	TP53	D48E, D9E	Li-Fraumeni syndrome	VCV000141056	17	7579543	17	7676225	141056	150770	rs587781460	NC_000017.11:7676224:G:T	single nucleotide variant	missense variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.143A>G (p.Asp48Gly)	TP53	D48G, D9G	Li-Fraumeni syndrome	VCV002795844	17	7579544	17	7676226	2795844	2958263	rs2543635404	NC_000017.11:7676225:T:C	single nucleotide variant	missense variant|non-coding transcript variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_000546.6(TP53):c.139C>T (p.Pro47Ser)	TP53	P47S, P8S	Li-Fraumeni syndrome|Cervical cancer	VCV000043588	17	7579548	17	7676230	43588	52757	rs1800371	NC_000017.11:7676229:G:A	single nucleotide variant	missense variant	Benign	Aug 5, 2024	reviewed by expert panel				Uncertain significance	Jun 30, 2020	no assertion criteria provided	
NM_000546.6(TP53):c.107C>A (p.Pro36Gln)	TP53	P36Q	Li-Fraumeni syndrome	VCV000141597	17	7579580	17	7676262	141597	151311	rs587781866	NC_000017.11:7676261:G:T	single nucleotide variant	missense variant|5 prime UTR variant	Benign	Sep 6, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.105G>C (p.Leu35Phe)	TP53	L35F	Li-Fraumeni syndrome	VCV000142562	17	7579582	17	7676264	142562	152276	rs121912661	NC_000017.11:7676263:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Sep 6, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.94C>G (p.Leu32Val)	TP53	L32V	Hereditary cancer-predisposing syndrome	VCV001767161	17	7579702	17	7676384	1767161	1821503	rs1555526920	NC_000017.11:7676383:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Oct 4, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.85A>G (p.Asn29Asp)	TP53	N29D	Hereditary cancer-predisposing syndrome	VCV000822586	17	7579711	17	7676393	822586	814522	rs1597375899	NC_000017.11:7676392:T:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Nov 25, 2019	criteria provided, single submitter							
NM_000546.6(TP53):c.62A>C (p.Asp21Ala)	TP53	D21A	Hereditary cancer-predisposing syndrome	VCV003972456	17	7579851	17	7676533	3972456	4089468		NC_000017.11:7676532:T:G	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Jun 5, 2025	criteria provided, single submitter							
NM_000546.6(TP53):c.28G>C (p.Val10Leu)	TP53	V10L	Li-Fraumeni syndrome 1	VCV000231387	17	7579885	17	7676567	231387	236519	rs535274413	NC_000017.11:7676566:C:G	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Aug 2, 2021	reviewed by expert panel							
NM_000546.6(TP53):c.28G>A (p.Val10Ile)	TP53	V10I	Li-Fraumeni syndrome	VCV000127806	17	7579885	17	7676567	127806	133263	rs535274413	NC_000017.11:7676566:C:T	single nucleotide variant	missense variant|5 prime UTR variant	Benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.23C>G (p.Pro8Arg)	TP53	P8R	Hereditary cancer-predisposing syndrome	VCV001790705	17	7579890	17	7676572	1790705	1841606	rs876659415	NC_000017.11:7676571:G:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Feb 28, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.23C>T (p.Pro8Leu)	TP53	P8L	Hereditary cancer-predisposing syndrome	VCV000231868	17	7579890	17	7676572	231868	236520	rs876659415	NC_000017.11:7676571:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	May 15, 2015	criteria provided, single submitter							
NM_000546.6(TP53):c.21T>G (p.Asp7Glu)	TP53	D7E	Hereditary cancer-predisposing syndrome	VCV000485049	17	7579892	17	7676574	485049	479373	rs587781277	NC_000017.11:7676573:A:C	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Aug 14, 2017	criteria provided, single submitter							
NM_000546.6(TP53):c.21T>A (p.Asp7Glu)	TP53	D7E	Li-Fraumeni syndrome	VCV000140782	17	7579892	17	7676574	140782	150496	rs587781277	NC_000017.11:7676573:A:T	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Aug 5, 2024	reviewed by expert panel							
NM_000546.6(TP53):c.11C>A (p.Pro4Gln)	TP53	P4Q	Hereditary cancer-predisposing syndrome	VCV002450740	17	7579902	17	7676584	2450740	2423226	rs878854064	NC_000017.11:7676583:G:T	single nucleotide variant	missense variant|5 prime UTR variant|non-coding transcript variant	Likely benign	Nov 22, 2022	criteria provided, single submitter							
NM_000546.6(TP53):c.11C>T (p.Pro4Leu)	TP53	P4L	Li-Fraumeni syndrome	VCV000237941	17	7579902	17	7676584	237941	242994	rs878854064	NC_000017.11:7676583:G:A	single nucleotide variant	missense variant|5 prime UTR variant	Likely benign	Jan 16, 2025	reviewed by expert panel							
NM_001143992.2(WRAP53):c.31C>T (p.Pro11Ser)	TP53|WRAP53	P11S	Dyskeratosis congenita, autosomal recessive 3|Dyskeratosis Congenita, Recessive|not provided|Dyskeratosis congenita|Li-Fraumeni syndrome	VCV000325650	17	7591997	17	7688679	325650	330265	rs17880282	NC_000017.11:7688678:C:T	single nucleotide variant	missense variant	Benign/Likely benign	Jan 30, 2025	criteria provided, multiple submitters, no conflicts							
NM_001143992.2(WRAP53):c.202C>G (p.Arg68Gly)	TP53|WRAP53	R68G	not specified|not provided|Dyskeratosis congenita, autosomal recessive 3|Li-Fraumeni syndrome|Dyskeratosis congenita	VCV000261001	17	7592168	17	7688850	261001	256465	rs2287499	NC_000017.11:7688849:C:G	single nucleotide variant	missense variant	Benign	Feb 4, 2025	criteria provided, multiple submitters, no conflicts							
NM_001143992.2(WRAP53):c.407C>G (p.Pro136Arg)	TP53|WRAP53	P136R	Dyskeratosis Congenita, Recessive|not specified|not provided|Dyskeratosis congenita, autosomal recessive 3|Li-Fraumeni syndrome	VCV000261002	17	7592373	17	7689055	261002	256466	rs34067256	NC_000017.11:7689054:C:G	single nucleotide variant	missense variant	Benign/Likely benign	Feb 3, 2025	criteria provided, multiple submitters, no conflicts							
